Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
THYMO.SP_CD8_transitional: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 604 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Frailty, limited social support | SOCIO000017 | 23.30 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 2 | AHSP/CA2 ratio | PRORT000057 | 23.00 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 5 | 17 | |
| 3 | Pregnancy termination | BEHAV000010 | 18.18 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 4 | Dissociative disorder | PSYCH000012 | 16.63 | Psychiatric | Lymphocyte | 0 | 2 | 14 | 19 | |
| 5 | LAT2/YES1 ratio | PRORT001432 | 16.32 | Protein ratios | Hematopoietic progenitor | 10 | 2 | 6 | 7 | |
| 6 | CXCL10/CXCL11 ratio | PRORT000814 | 16.30 | Protein ratios | Hematopoietic progenitor | 5 | 4 | 9 | 12 | |
| 7 | EDAR/EGF ratio | PRORT000965 | 16.19 | Protein ratios | Lymphocyte | 3 | 4 | 12 | 35 | |
| 8 | ICAM4 levels | PROLV001007 | 15.92 | Protein levels | Lymphocyte | 53 | 2 | 13 | 33 | |
| 9 | CA2/HMBS ratio | PRORT000275 | 15.91 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 10 | Dietary restriction | DTSUP000009 | 15.58 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 11 | UCMA levels | PROLV002135 | 15.41 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 12 | Drink temperature | DTSUP000003 | 15.20 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 13 | RAB31 levels | PROLV001699 | 15.05 | Protein levels | Lymphocyte | 0 | 3 | 6 | 14 | |
| 14 | CD160 levels | PROLV000311 | 13.66 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 15 | Auditory performance | AUDIO000009 | 13.24 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 16 | SOD1 levels | PROLV001916 | 13.11 | Protein levels | Lymphocyte | 1 | 2 | 10 | 33 | |
| 17 | Medical condition | MISCL000028 | 13.07 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 18 | MAVS/MED18 ratio | PRORT001495 | 13.02 | Protein ratios | Lymphocyte | 20 | 6 | 15 | 39 | |
| 19 | ROR1/TNFRSF21 ratio | PRORT001748 | 12.97 | Protein ratios | Lymphocyte | 8 | 5 | 11 | 19 | |
| 20 | THY1/TNFRSF21 ratio | PRORT001836 | 12.91 | Protein ratios | Lymphocyte | 1 | 1 | 4 | 6 | |
| 21 | Pregnancy complication, abortive | REPRO000027 | 12.34 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 22 | BPIFB1 levels | PROLV000210 | 12.26 | Protein levels | Myeloid | 54 | 2 | 11 | 20 | |
| 23 | YOD1 levels | PROLV002206 | 11.90 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 24 | Retinal pigment epithelium thickness | OPHTH000042 | 11.81 | Ophthalmic | Myeloid | 6 | 3 | 12 | 13 | |
| 25 | LHPP levels | PROLV001209 | 11.66 | Protein levels | Lymphocyte | 19 | 2 | 14 | 44 | |
| 26 | DTYMK levels | PROLV000661 | 11.59 | Protein levels | Lymphocyte | 6 | 3 | 9 | 30 | |
| 27 | Nutritional and metabolic symptoms | METBL000016 | 11.20 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 28 | RLN2 levels | PROLV001736 | 10.71 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 29 | Hyperthyroidism, autoimmune | IMMUN000014 | 10.59 | Immunologic | Lymphocyte | 60 | 2 | 13 | 28 | |
| 30 | EDAR/SPARC ratio | PRORT000979 | 10.56 | Protein ratios | Platelet | 7 | 3 | 9 | 17 | |
| 31 | CALCOCO1/PFKFB2 ratio | PRORT000301 | 10.47 | Protein ratios | Myeloid | 1 | 5 | 10 | 23 | |
| 32 | Lymphangioleiomyomatosis | RESPI000014 | 10.15 | Respiratory | Muscle / cardiac | 0 | 3 | 7 | 25 | |
| 33 | Social activity | SOCIO000020 | 10.13 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 34 | Sciatica | NEURO000033 | 10.05 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 35 | FLT3/FLT3LG ratio | PRORT001165 | 10.01 | Protein ratios | Lymphocyte | 5 | 5 | 11 | 30 | |
| 36 | CD160/NCR1 ratio | PRORT000378 | 9.75 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 37 | CRADD/FADD ratio | PRORT000745 | 9.73 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 38 | Social support | SOCIO000022 | 9.42 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 39 | Thyroid peroxidase antibodies | IMMUN000045 | 9.14 | Immunologic | Lymphocyte | 20 | 2 | 14 | 22 | |
| 40 | Professional qualification | SOCIO000003 | 9.11 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 41 | GLA levels | PROLV000893 | 9.11 | Protein levels | Lymphocyte | 2 | 3 | 6 | 30 | |
| 42 | Congenital malformation | REPRO000003 | 9.09 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 43 | AHSP levels | PROLV000066 | 9.08 | Protein levels | Muscle / cardiac | 0 | 1 | 4 | 13 | |
| 44 | DBI/EDAR ratio | PRORT000861 | 9.05 | Protein ratios | Myeloid | 37 | 3 | 6 | 16 | |
| 45 | Obesity | METBL000008 | 8.99 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 46 | UROD levels | PROLV002143 | 8.94 | Protein levels | Lymphocyte | 2 | 2 | 9 | 33 | |
| 47 | EDAR/SNAP23 ratio | PRORT000978 | 8.83 | Protein ratios | Myeloid | 33 | 3 | 15 | 20 | |
| 48 | ITGB1BP2/TIA1 ratio | PRORT001389 | 8.68 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 49 | CRISP2 levels | PROLV000524 | 8.65 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 50 | BOLA2 or BOLA2B levels | PROLV000208 | 8.47 | Protein levels | Lymphocyte | 3 | 2 | 7 | 24 | |
| 51 | HMBS/PKLR ratio | PRORT001288 | 8.43 | Protein ratios | Lymphocyte | 29 | 1 | 15 | 23 | |
| 52 | DNAJB2 levels | PROLV000632 | 8.20 | Protein levels | Lymphocyte | 19 | 4 | 17 | 45 | |
| 53 | CD160/KLRB1 ratio | PRORT000377 | 8.15 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 54 | EPHB6/LAYN ratio | PRORT001037 | 8.12 | Protein ratios | Muscle / cardiac | 6 | 2 | 3 | 13 | |
| 55 | CCN2/EDAR ratio | PRORT000363 | 8.04 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 10 | 14 | |
| 56 | EDAR/TACC3 ratio | PRORT000980 | 8.00 | Protein ratios | Myeloid | 9 | 3 | 14 | 21 | |
| 57 | CXCL8 levels | PROLV000586 | 7.93 | Protein levels | Myeloid | 39 | 3 | 11 | 20 | |
| 58 | OLFM4 levels | PROLV001466 | 7.92 | Protein levels | Myeloid | 42 | 2 | 8 | 17 | |
| 59 | CLEC4G/MERTK ratio | PRORT000661 | 7.83 | Protein ratios | Myeloid | 78 | 5 | 18 | 29 | |
| 60 | CLEC14A/TNFRSF21 ratio | PRORT000629 | 7.83 | Protein ratios | Neural / glial | 5 | 1 | 1 | 8 | |
| 61 | FCRL5/MZB1 ratio | PRORT001135 | 7.82 | Protein ratios | B / plasma cell | 4 | 2 | 3 | 3 | |
| 62 | Occupational physical activity | BEHAV000006 | 7.76 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 63 | Social relationships | SOCIO000021 | 7.75 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 64 | SLAMF8 levels | PROLV001877 | 7.74 | Protein levels | Myeloid | 34 | 5 | 12 | 28 | |
| 65 | RETN levels | PROLV001725 | 7.71 | Protein levels | Myeloid | 37 | 2 | 5 | 7 | |
| 66 | Reaction time | PSYCH000010 | 7.71 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 67 | SSNA1 levels | PROLV001950 | 7.67 | Protein levels | Platelet | 5 | 7 | 14 | 25 | |
| 68 | Social and economic stability | SOCIO000028 | 7.66 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 69 | Sexual behaviour | BEHAV000012 | 7.62 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 70 | Grain and bakery preference | DTSUP000013 | 7.47 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 71 | SNRPB2 levels | PROLV001910 | 7.44 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 72 | EDA2R levels | PROLV000673 | 7.41 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 73 | Housing type | SOCIO000013 | 7.27 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 74 | Chronic illness or disability | MISCL000004 | 6.98 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 75 | EBAG9/FKBP5 ratio | PRORT000958 | 6.94 | Protein ratios | Lymphocyte | 1 | 5 | 8 | 24 | |
| 76 | WFDC1 levels | PROLV002188 | 6.91 | Protein levels | B / plasma cell | 2 | 2 | 3 | 5 | |
| 77 | Pain, none | MSKEL000041 | 6.88 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 78 | Handedness | BEHAV000003 | 6.87 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 79 | LAYN/ULBP2 ratio | PRORT001435 | 6.72 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 80 | APLP1 levels | PROLV000115 | 6.70 | Protein levels | Myeloid | 32 | 2 | 10 | 19 | |
| 81 | EPO/TFRC ratio | PRORT001040 | 6.67 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 82 | EBAG9/TBCC ratio | PRORT000962 | 6.64 | Protein ratios | Muscle / cardiac | 5 | 3 | 16 | 46 | |
| 83 | PFKM levels | PROLV001541 | 6.64 | Protein levels | Lymphocyte | 0 | 3 | 15 | 30 | |
| 84 | EDAR/IRAK4 ratio | PRORT000971 | 6.61 | Protein ratios | Myeloid | 38 | 2 | 13 | 16 | |
| 85 | Electronic device use | BEHAV000017 | 6.55 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 86 | EDAR/ENO2 ratio | PRORT000966 | 6.49 | Protein ratios | Myeloid | 31 | 4 | 7 | 19 | |
| 87 | ST13 levels | PROLV001951 | 6.47 | Protein levels | Lymphocyte | 2 | 5 | 15 | 39 | |
| 88 | METAP2/PLPBP ratio | PRORT001524 | 6.44 | Protein ratios | Granulosa cell | 7 | 2 | 9 | 9 | |
| 89 | NCAN levels | PROLV001379 | 6.30 | Protein levels | Myeloid | 72 | 3 | 4 | 12 | |
| 90 | Drug poisoning | MISCL000036 | 6.21 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 91 | NELL2/SEZ6L ratio | PRORT001585 | 6.20 | Protein ratios | Lymphocyte | 2 | 4 | 16 | 31 | |
| 92 | Birth weight availability | MISCL000005 | 6.18 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 93 | EDAR/SERPINB1 ratio | PRORT000977 | 6.17 | Protein ratios | Myeloid | 29 | 2 | 8 | 14 | |
| 94 | PPM1B levels | PROLV001610 | 6.17 | Protein levels | Lymphocyte | 11 | 2 | 12 | 22 | |
| 95 | AHSP/HMBS ratio | PRORT000058 | 6.17 | Protein ratios | Lymphocyte | 33 | 4 | 16 | 48 | |
| 96 | Sedentary behaviour | BEHAV000008 | 6.15 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 97 | SPESP1 levels | PROLV001926 | 6.13 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 98 | Erythrocyte | HEMAT000005 | 6.09 | Hematologic | Hematopoietic progenitor | 3,061 | 3 | 7 | 17 | |
| 99 | GLO1 levels | PROLV000895 | 6.06 | Protein levels | Lymphocyte | 0 | 2 | 7 | 31 | |
| 100 | Glucose regulation disorder | METBL000038 | 6.05 | Metabolic | Lymphocyte | 36 | 2 | 5 | 17 | |
| 101 | DKK3/LTBP2 ratio | PRORT000908 | 6.02 | Protein ratios | Neural / glial | 1 | 1 | 5 | 13 | |
| 102 | CALCOCO1/TJAP1 ratio | PRORT000303 | 6.01 | Protein ratios | Muscle / cardiac | 0 | 4 | 14 | 32 | |
| 103 | Spondylopathy | MSKEL000080 | 5.99 | Musculoskeletal | Stromal / connective | 21 | 2 | 2 | 10 | |
| 104 | CALCOCO1/MAP3K5 ratio | PRORT000298 | 5.93 | Protein ratios | B / plasma cell | 0 | 4 | 13 | 30 | |
| 105 | SEPTIN8 levels | PROLV001814 | 5.92 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 106 | CRH levels | PROLV000520 | 5.91 | Protein levels | Hematopoietic progenitor | 35 | 1 | 1 | 7 | |
| 107 | CD48/CRTAM ratio | PRORT000463 | 5.87 | Protein ratios | Lymphocyte | 45 | 2 | 15 | 25 | |
| 108 | SLC4A1 levels | PROLV001882 | 5.87 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 109 | Psychiatric care | PSYCH000015 | 5.87 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 110 | Chronic respiratory disease | RESPI000003 | 5.86 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 111 | RBFOX3 levels | PROLV001708 | 5.84 | Protein levels | Lymphocyte | 0 | 2 | 16 | 35 | |
| 112 | CLEC4C levels | PROLV000451 | 5.82 | Protein levels | Myeloid | 124 | 4 | 9 | 15 | |
| 113 | COL28A1 levels | PROLV000487 | 5.79 | Protein levels | B / plasma cell | 11 | 0 | 4 | 14 | |
| 114 | SERPINB8 levels | PROLV001826 | 5.79 | Protein levels | Myeloid | 18 | 5 | 6 | 17 | |
| 115 | Viral wart | IMMUN000079 | 5.78 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 116 | ITGB1BP2/PTPN6 ratio | PRORT001386 | 5.73 | Protein ratios | Hematopoietic progenitor | 21 | 6 | 14 | 34 | |
| 117 | CD40LG/EDAR ratio | PRORT000448 | 5.71 | Protein ratios | Myeloid | 8 | 2 | 10 | 16 | |
| 118 | CA1 levels | PROLV000239 | 5.68 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 119 | TNFRSF13C levels | PROLV002064 | 5.68 | Protein levels | B / plasma cell | 45 | 3 | 7 | 22 | |
| 120 | ALOX15B levels | PROLV000081 | 5.64 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 121 | Sacroiliitis | MSKEL000020 | 5.64 | Musculoskeletal | Muscle / cardiac | 35 | 4 | 9 | 31 | |
| 122 | CRELD1 levels | PROLV000518 | 5.63 | Protein levels | Myeloid | 51 | 2 | 8 | 20 | |
| 123 | PTPN1/WWP2 ratio | PRORT001718 | 5.61 | Protein ratios | Muscle / cardiac | 12 | 2 | 14 | 27 | |
| 124 | Anterior eye disorder | OPHTH000001 | 5.58 | Ophthalmic | Lymphocyte | 38 | 3 | 15 | 21 | |
| 125 | MCEE levels | PROLV001284 | 5.58 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 126 | FAM13A levels | PROLV000759 | 5.55 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 127 | KIFBP/LYN ratio | PRORT001403 | 5.55 | Protein ratios | Myeloid | 9 | 4 | 14 | 37 | |
| 128 | PDGFA/SPARC ratio | PRORT001637 | 5.55 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 129 | NXPH3 levels | PROLV001458 | 5.54 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 130 | Smoking dependency | PSYCH000047 | 5.54 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 131 | EBAG9/EDAR ratio | PRORT000957 | 5.54 | Protein ratios | Myeloid | 27 | 4 | 12 | 16 | |
| 132 | EDAR/YES1 ratio | PRORT000985 | 5.53 | Protein ratios | Myeloid | 30 | 5 | 12 | 27 | |
| 133 | IL2RA/NCR1 ratio | PRORT001351 | 5.52 | Protein ratios | Lymphocyte | 29 | 3 | 8 | 38 | |
| 134 | IL18 levels | PROLV001054 | 5.50 | Protein levels | Myeloid | 48 | 2 | 16 | 26 | |
| 135 | CRADD/EDAR ratio | PRORT000743 | 5.49 | Protein ratios | Myeloid | 37 | 4 | 5 | 13 | |
| 136 | PDGFA/SERPINE1 ratio | PRORT001635 | 5.49 | Protein ratios | Hematopoietic progenitor | 33 | 5 | 9 | 12 | |
| 137 | PROS1 levels | PROLV001640 | 5.42 | Protein levels | Hepatocyte | 37 | 1 | 6 | 9 | |
| 138 | GCNT1 levels | PROLV000868 | 5.41 | Protein levels | Myeloid | 33 | 0 | 4 | 12 | |
| 139 | ABHD14B/SCRN1 ratio | PRORT000006 | 5.41 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 7 | 10 | |
| 140 | DAPP1/ITGB1BP2 ratio | PRORT000854 | 5.40 | Protein ratios | Myeloid | 21 | 5 | 19 | 31 | |
| 141 | CRTAM/ICAM3 ratio | PRORT000770 | 5.39 | Protein ratios | Lymphocyte | 23 | 2 | 20 | 46 | |
| 142 | CRADD/HSPA1A ratio | PRORT000747 | 5.37 | Protein ratios | Neural / glial | 20 | 3 | 6 | 17 | |
| 143 | Frailty, general | MISCL000039 | 5.35 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 144 | EDAR/F2R ratio | PRORT000969 | 5.32 | Protein ratios | Platelet | 43 | 3 | 13 | 27 | |
| 145 | SNAP29/TJAP1 ratio | PRORT001799 | 5.30 | Protein ratios | Myeloid | 27 | 5 | 14 | 22 | |
| 146 | PSME2 levels | PROLV001659 | 5.27 | Protein levels | Vascular | 1 | 4 | 9 | 30 | |
| 147 | Obstetric trauma | REPRO000039 | 5.24 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 148 | Legume preference | DTSUP000014 | 5.21 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 149 | IL18BP/ROR1 ratio | PRORT001346 | 5.21 | Protein ratios | Myeloid | 6 | 3 | 14 | 30 | |
| 150 | LAIR1 levels | PROLV001176 | 5.19 | Protein levels | Myeloid | 23 | 4 | 9 | 17 | |
| 151 | EDAR/TXNDC5 ratio | PRORT000984 | 5.17 | Protein ratios | Myeloid | 50 | 2 | 7 | 16 | |
| 152 | EBAG9/TBCB ratio | PRORT000961 | 5.16 | Protein ratios | Myeloid | 0 | 2 | 7 | 16 | |
| 153 | ICA1/TANK ratio | PRORT001320 | 5.16 | Protein ratios | Neural / glial | 0 | 3 | 4 | 9 | |
| 154 | FLT3 levels | PROLV000816 | 5.12 | Protein levels | Myeloid | 50 | 4 | 11 | 22 | |
| 155 | EDAR/TNFSF12 ratio | PRORT000982 | 5.11 | Protein ratios | Hematopoietic progenitor | 34 | 5 | 9 | 21 | |
| 156 | Loud music exposure | MISCL000006 | 5.07 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 157 | CA1/TGM2 ratio | PRORT000270 | 5.06 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 158 | CHCHD10 levels | PROLV000424 | 5.06 | Protein levels | Muscle / cardiac | 0 | 4 | 8 | 21 | |
| 159 | DBNL/EDAR ratio | PRORT000865 | 5.04 | Protein ratios | Myeloid | 31 | 4 | 14 | 22 | |
| 160 | Skin elastin | DERMA000042 | 5.01 | Dermatologic | Neural / glial | 0 | 4 | 5 | 19 | |
| 161 | EPS8L2 levels | PROLV000723 | 5.00 | Protein levels | Stromal / connective | 20 | 0 | 10 | 20 | |
| 162 | MYL3 levels | PROLV001360 | 4.99 | Protein levels | Muscle / cardiac | 42 | 3 | 8 | 20 | |
| 163 | ERMAP levels | PROLV000729 | 4.98 | Protein levels | Myeloid | 44 | 4 | 10 | 22 | |
| 164 | LTBR/SIRPB1 ratio | PRORT001466 | 4.95 | Protein ratios | Lymphocyte | 1 | 1 | 3 | 17 | |
| 165 | Family history, asthma | IMMUN000047 | 4.91 | Immunologic | Lymphocyte | 5 | 3 | 17 | 26 | |
| 166 | PHYKPL levels | PROLV001552 | 4.91 | Protein levels | Lymphocyte | 3 | 2 | 6 | 16 | |
| 167 | IGLL1 levels | PROLV001036 | 4.90 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 168 | Taste preference | DTSUP000023 | 4.90 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 169 | PRG2 levels | PROLV001628 | 4.83 | Protein levels | Lymphocyte | 70 | 4 | 8 | 35 | |
| 170 | CABP2 levels | PROLV000249 | 4.81 | Protein levels | B / plasma cell | 21 | 2 | 4 | 10 | |
| 171 | FCRL1 levels | PROLV000783 | 4.80 | Protein levels | B / plasma cell | 101 | 2 | 7 | 15 | |
| 172 | Vaccination | IMMUN000085 | 4.79 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 173 | Implant | MISCL000025 | 4.79 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 174 | PTPRR levels | PROLV001680 | 4.77 | Protein levels | Epithelial | 0 | 0 | 7 | 15 | |
| 175 | Smoking behaviour | PSYCH000046 | 4.75 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 176 | CRTAM levels | PROLV000530 | 4.74 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 177 | CD63/EDAR ratio | PRORT000486 | 4.70 | Protein ratios | Myeloid | 0 | 5 | 10 | 12 | |
| 178 | GNPDA2 levels | PROLV000906 | 4.65 | Protein levels | Lymphocyte | 0 | 3 | 2 | 7 | |
| 179 | MAVS/TBL1X ratio | PRORT001501 | 4.64 | Protein ratios | Lymphocyte | 1 | 2 | 14 | 35 | |
| 180 | AK1 levels | PROLV000070 | 4.61 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 181 | MAP3K5/ZBTB16 ratio | PRORT001489 | 4.60 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 182 | NPL levels | PROLV001423 | 4.59 | Protein levels | Myeloid | 36 | 4 | 8 | 19 | |
| 183 | EDAR/PRDX5 ratio | PRORT000974 | 4.58 | Protein ratios | Myeloid | 42 | 2 | 10 | 16 | |
| 184 | GCHFR levels | PROLV000867 | 4.58 | Protein levels | Hepatocyte | 2 | 2 | 13 | 40 | |
| 185 | IL15 levels | PROLV001048 | 4.53 | Protein levels | Lymphocyte | 114 | 2 | 12 | 20 | |
| 186 | ENO2/RWDD1 ratio | PRORT001029 | 4.51 | Protein ratios | Lymphocyte | 15 | 4 | 16 | 49 | |
| 187 | Schizophrenia | PSYCH000036 | 4.51 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 188 | Fruit preference | DTSUP000012 | 4.50 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 189 | PCDH17/ROBO1 ratio | PRORT001625 | 4.48 | Protein ratios | Granulosa cell | 9 | 2 | 4 | 8 | |
| 190 | FKBP5/TBCC ratio | PRORT001159 | 4.47 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 191 | Amino acid metabolites | METAB000002 | 4.47 | Metabolites | Neural / glial | 0 | 0 | 7 | 11 | |
| 192 | CRACR2A/IRAG2 ratio | PRORT000740 | 4.42 | Protein ratios | Hepatocyte | 1 | 3 | 11 | 37 | |
| 193 | CXCL5/EDAR ratio | PRORT000827 | 4.41 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 194 | CAPG levels | PROLV000262 | 4.41 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 195 | BCAN/MOG ratio | PRORT000217 | 4.41 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 196 | EDAR/F11R ratio | PRORT000968 | 4.41 | Protein ratios | Myeloid | 23 | 3 | 7 | 20 | |
| 197 | CPXM1/SPARC ratio | PRORT000736 | 4.41 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 8 | 22 | |
| 198 | Abnormal lung findings | RESPI000026 | 4.39 | Respiratory | Hepatocyte | 1 | 2 | 7 | 19 | |
| 199 | Cancer, Respiratory system | MALIG000027 | 4.37 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 200 | SKAP1 levels | PROLV001872 | 4.36 | Protein levels | Lymphocyte | 90 | 2 | 11 | 18 | |
| 201 | APP/NID2 ratio | PRORT000129 | 4.35 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 202 | TBCB/TBCC ratio | PRORT001827 | 4.33 | Protein ratios | Myeloid | 1 | 2 | 10 | 23 | |
| 203 | CA1/HMBS ratio | PRORT000269 | 4.33 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 204 | FCRL2 levels | PROLV000784 | 4.33 | Protein levels | B / plasma cell | 91 | 1 | 4 | 7 | |
| 205 | Intervertebral disc disorder | MSKEL000076 | 4.33 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 206 | CXCL5/PLXNA4 ratio | PRORT000829 | 4.31 | Protein ratios | Myeloid | 0 | 5 | 14 | 31 | |
| 207 | TNFRSF13C/TNFSF13B ratio | PRORT001849 | 4.30 | Protein ratios | B / plasma cell | 32 | 3 | 7 | 28 | |
| 208 | ENO2/PLXNA4 ratio | PRORT001027 | 4.28 | Protein ratios | Myeloid | 5 | 4 | 13 | 39 | |
| 209 | BANK1/FOXO1 ratio | PRORT000204 | 4.24 | Protein ratios | Muscle / cardiac | 2 | 3 | 9 | 19 | |
| 210 | Vaccination adverse effects | IMMUN000008 | 4.23 | Immunologic | Muscle / cardiac | 0 | 3 | 7 | 37 | |
| 211 | GHR levels | PROLV000885 | 4.21 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 212 | CRTAM/LY9 ratio | PRORT000772 | 4.19 | Protein ratios | Lymphocyte | 31 | 3 | 16 | 28 | |
| 213 | Cancer, Lung | MALIG000019 | 4.19 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 214 | KLK6/MOG ratio | PRORT001409 | 4.17 | Protein ratios | Myeloid | 8 | 4 | 12 | 15 | |
| 215 | CD69/EDAR ratio | PRORT000491 | 4.16 | Protein ratios | Myeloid | 21 | 4 | 11 | 22 | |
| 216 | CEACAM8/RNASE3 ratio | PRORT000589 | 4.13 | Protein ratios | Hematopoietic progenitor | 2 | 3 | 4 | 11 | |
| 217 | IMPACT levels | PROLV001085 | 4.12 | Protein levels | Muscle / cardiac | 1 | 5 | 11 | 38 | |
| 218 | BIN2/FYB1 ratio | PRORT000232 | 4.12 | Protein ratios | Myeloid | 1 | 3 | 9 | 21 | |
| 219 | Cereal preference | DTSUP000010 | 4.12 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 220 | Prurigo | DERMA000017 | 4.11 | Dermatologic | Lymphocyte | 1 | 2 | 8 | 29 | |
| 221 | NPC2 levels | PROLV001419 | 4.08 | Protein levels | Myeloid | 24 | 1 | 5 | 9 | |
| 222 | EDAR/ITGB1BP2 ratio | PRORT000972 | 4.07 | Protein ratios | Myeloid | 49 | 5 | 17 | 20 | |
| 223 | PTRHD1 levels | PROLV001683 | 4.07 | Protein levels | Lymphocyte | 1 | 3 | 8 | 29 | |
| 224 | CRADD/DARS1 ratio | PRORT000742 | 4.07 | Protein ratios | Myeloid | 2 | 2 | 11 | 12 | |
| 225 | GYS1/PPP1R2 ratio | PRORT001255 | 4.06 | Protein ratios | Melanocyte | 0 | 1 | 5 | 12 | |
| 226 | AXIN1/MAP2K6 ratio | PRORT000174 | 4.04 | Protein ratios | Granulosa cell | 0 | 3 | 5 | 12 | |
| 227 | Meat preference | DTSUP000015 | 4.04 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 228 | HSBP1 levels | PROLV000992 | 4.04 | Protein levels | Muscle / cardiac | 19 | 7 | 10 | 27 | |
| 229 | Phospholipid species | LIPID000064 | 4.03 | Lipids | Hepatocyte | 23 | 2 | 4 | 16 | |
| 230 | Cancer, Oropharynx | MALIG000022 | 4.01 | Malignancy | Neural / glial | 0 | 6 | 13 | 22 | |
| 231 | Alanine | METAB000017 | 4.01 | Metabolites | Hepatocyte | 251 | 1 | 5 | 12 | |
| 232 | AXIN1/CALCOCO1 ratio | PRORT000165 | 4.01 | Protein ratios | Granulosa cell | 3 | 4 | 14 | 33 | |
| 233 | JAM3 levels | PROLV001125 | 4.00 | Protein levels | Lymphocyte | 3 | 2 | 6 | 17 | |
| 234 | THOP1 levels | PROLV002028 | 4.00 | Protein levels | Muscle / cardiac | 14 | 5 | 6 | 13 | |
| 235 | ESM1 levels | PROLV000734 | 3.99 | Protein levels | Myeloid | 169 | 1 | 6 | 12 | |
| 236 | Clonal haematopoiesis | HEMAT000015 | 3.98 | Hematologic | Myeloid | 54 | 2 | 3 | 15 | |
| 237 | SMNDC1 levels | PROLV001898 | 3.98 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 238 | Nephrotic syndrome | NEPHR000011 | 3.95 | Nephrourologic | B / plasma cell | — | 3 | 8 | 28 | |
| 239 | CALCOCO1/IKBKG ratio | PRORT000295 | 3.92 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 240 | CD40/CRELD2 ratio | PRORT000442 | 3.92 | Protein ratios | Hepatocyte | 11 | 3 | 5 | 15 | |
| 241 | Medication, antispasmodic | GASTR000015 | 3.92 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 242 | LMNB1 levels | PROLV001217 | 3.91 | Protein levels | Myeloid | 0 | 3 | 9 | 10 | |
| 243 | Hospital discharge | MISCL000023 | 3.91 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 244 | ENO3 levels | PROLV000707 | 3.91 | Protein levels | Muscle / cardiac | 33 | 4 | 18 | 37 | |
| 245 | EDAR/SDC4 ratio | PRORT000976 | 3.91 | Protein ratios | Hematopoietic progenitor | 25 | 4 | 8 | 17 | |
| 246 | AFM levels | PROLV000052 | 3.90 | Protein levels | Hepatocyte | 24 | 1 | 7 | 20 | |
| 247 | MAD1L1 levels | PROLV001257 | 3.89 | Protein levels | Myeloid | 6 | 5 | 12 | 26 | |
| 248 | Body mass index, BMI | BMORP000002 | 3.89 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 249 | CCL13/CCL17 ratio | PRORT000337 | 3.88 | Protein ratios | Myeloid | 17 | 3 | 8 | 27 | |
| 250 | EXTL1 levels | PROLV000738 | 3.88 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 251 | DEFA1 or DEFA1B levels | PROLV000613 | 3.87 | Protein levels | Myeloid | 56 | 1 | 6 | 5 | |
| 252 | F11 levels | PROLV000741 | 3.87 | Protein levels | Hepatocyte | 103 | 3 | 8 | 13 | |
| 253 | METAP1D/VASH1 ratio | PRORT001522 | 3.86 | Protein ratios | Hematopoietic progenitor | 4 | 2 | 5 | 11 | |
| 254 | CD58/SIRPB1 ratio | PRORT000479 | 3.86 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 2 | 5 | |
| 255 | Graves disease | IMMUN000027 | 3.86 | Immunologic | Lymphocyte | 94 | 1 | 11 | 18 | |
| 256 | RTN4R levels | PROLV001762 | 3.85 | Protein levels | Myeloid | 101 | 2 | 5 | 12 | |
| 257 | Spondylosis | MSKEL000081 | 3.83 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 258 | SCRG1 levels | PROLV001793 | 3.81 | Protein levels | Stromal / connective | 1 | 0 | 6 | 7 | |
| 259 | LYZL2 levels | PROLV001255 | 3.81 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 260 | EPPK1 levels | PROLV000722 | 3.80 | Protein levels | Myeloid | 14 | 3 | 7 | 14 | |
| 261 | Carotid intima-media thickness | VASCU000053 | 3.80 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 262 | FYN levels | PROLV000843 | 3.80 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 263 | BMP6/SPINT2 ratio | PRORT000244 | 3.79 | Protein ratios | Lymphocyte | 10 | 2 | 8 | 27 | |
| 264 | Hyperparathyroidism | ENDOC000004 | 3.78 | Endocrine | Hepatocyte | 0 | 3 | 8 | 17 | |
| 265 | BCR/GOPC ratio | PRORT000225 | 3.78 | Protein ratios | Hepatocyte | 4 | 3 | 10 | 33 | |
| 266 | TCL1A levels | PROLV002002 | 3.78 | Protein levels | B / plasma cell | 115 | 2 | 6 | 13 | |
| 267 | CD160/CXCL16 ratio | PRORT000376 | 3.77 | Protein ratios | Lymphocyte | 12 | 2 | 13 | 32 | |
| 268 | NAP1L4 levels | PROLV001374 | 3.76 | Protein levels | Lymphocyte | 15 | 3 | 9 | 33 | |
| 269 | PDGFB/SPARC ratio | PRORT001645 | 3.76 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 270 | Ocular alignment procedures | OPHTH000026 | 3.74 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 271 | ATF6 levels | PROLV000157 | 3.74 | Protein levels | Myeloid | 5 | 4 | 11 | 19 | |
| 272 | Disability allowance | SOCIO000019 | 3.73 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 273 | CRELD2/TXNDC5 ratio | PRORT000758 | 3.68 | Protein ratios | Myeloid | 2 | 3 | 9 | 11 | |
| 274 | Family history, lung cancer | MALIG000039 | 3.67 | Malignancy | Lymphocyte | 7 | 2 | 7 | 21 | |
| 275 | STAMBP/WWP2 ratio | PRORT001817 | 3.67 | Protein ratios | Muscle / cardiac | 8 | 4 | 9 | 20 | |
| 276 | CHMP1A levels | PROLV000431 | 3.66 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 277 | Lacrimal disorder | OPHTH000020 | 3.66 | Ophthalmic | Neural / glial | 0 | 0 | 2 | 11 | |
| 278 | MDH1 levels | PROLV001289 | 3.65 | Protein levels | Myeloid | 2 | 3 | 9 | 19 | |
| 279 | SMAD3 levels | PROLV001896 | 3.64 | Protein levels | Myeloid | 3 | 4 | 8 | 14 | |
| 280 | UGDH levels | PROLV002138 | 3.64 | Protein levels | B / plasma cell | 21 | 4 | 12 | 33 | |
| 281 | TP53I3 levels | PROLV002091 | 3.63 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 282 | SLITRK1 levels | PROLV001888 | 3.62 | Protein levels | Myeloid | 39 | 1 | 8 | 10 | |
| 283 | DECR1/MAP2K6 ratio | PRORT000882 | 3.62 | Protein ratios | Muscle / cardiac | 19 | 3 | 10 | 16 | |
| 284 | SEMA4D/TREML2 ratio | PRORT001771 | 3.62 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 6 | 24 | |
| 285 | RAP1A levels | PROLV001704 | 3.61 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 286 | MAP2K6/TBL1X ratio | PRORT001487 | 3.60 | Protein ratios | Myeloid | 10 | 4 | 12 | 28 | |
| 287 | Immune cell marker, pDC | HEMAT000028 | 3.59 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 288 | Parental longevity | AGING000003 | 3.58 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 289 | ARSA/GUSB ratio | PRORT000143 | 3.57 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 290 | CXCL16 levels | PROLV000581 | 3.57 | Protein levels | Lymphocyte | 67 | 3 | 13 | 36 | |
| 291 | Lipid unsaturation | LIPID000079 | 3.56 | Lipids | Lymphocyte | 10 | 1 | 13 | 40 | |
| 292 | Transport mode | BEHAV000009 | 3.55 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 293 | KIR2DL3 levels | PROLV001142 | 3.54 | Protein levels | Lymphocyte | 134 | 2 | 10 | 19 | |
| 294 | Hypothyroidism, subclinical in pregnancy | ENDOC000016 | 3.53 | Endocrine | Hematopoietic progenitor | 0 | 1 | 4 | 8 | |
| 295 | CAPS levels | PROLV000264 | 3.52 | Protein levels | Hematopoietic progenitor | 43 | 2 | 5 | 11 | |
| 296 | Ocular refraction | OPHTH000033 | 3.52 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 297 | Skin and soft tissue infection | IMMUN000073 | 3.51 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 298 | TBCA levels | PROLV001998 | 3.51 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 299 | GRAP2/SRC ratio | PRORT001246 | 3.50 | Protein ratios | Lymphocyte | 10 | 2 | 7 | 13 | |
| 300 | CALCA levels | PROLV000255 | 3.49 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 301 | Memory function | PSYCH000007 | 3.49 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 302 | FCRL3 levels | PROLV000785 | 3.48 | Protein levels | Lymphocyte | 48 | 2 | 9 | 18 | |
| 303 | CTF1/ITGB1BP2 ratio | PRORT000793 | 3.48 | Protein ratios | Hematopoietic progenitor | 18 | 4 | 10 | 21 | |
| 304 | CST7 levels | PROLV000552 | 3.47 | Protein levels | Myeloid | 39 | 4 | 11 | 22 | |
| 305 | Cutaneous haemangioma | DERMA000003 | 3.46 | Dermatologic | Myeloid | 1 | 1 | 7 | 12 | |
| 306 | Spondyloarthritis | IMMUN000044 | 3.46 | Immunologic | Myeloid | 110 | 4 | 8 | 20 | |
| 307 | ADAM8 levels | PROLV000029 | 3.45 | Protein levels | Myeloid | 76 | 3 | 8 | 14 | |
| 308 | CASP3/LYN ratio | PRORT000314 | 3.45 | Protein ratios | Myeloid | 1 | 2 | 14 | 44 | |
| 309 | PTPRC levels | PROLV001674 | 3.44 | Protein levels | Lymphocyte | 55 | 2 | 13 | 35 | |
| 310 | MANSC1/PODXL2 ratio | PRORT001484 | 3.43 | Protein ratios | Hepatocyte | 3 | 2 | 10 | 22 | |
| 311 | Basophil | HEMAT000029 | 3.42 | Hematologic | Myeloid | 728 | 2 | 8 | 13 | |
| 312 | SEZ6 levels | PROLV001840 | 3.42 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 313 | EDAR/TREML2 ratio | PRORT000983 | 3.41 | Protein ratios | Platelet | 14 | 2 | 6 | 11 | |
| 314 | LGALS9 levels | PROLV001207 | 3.41 | Protein levels | Myeloid | 18 | 0 | 4 | 6 | |
| 315 | CXCL3/CXCL5 ratio | PRORT000825 | 3.41 | Protein ratios | Myeloid | 8 | 3 | 14 | 24 | |
| 316 | Upper gastrointestinal disorder | GASTR000054 | 3.41 | Gastrointestinal | Myeloid | 0 | 1 | 7 | 13 | |
| 317 | PAXX levels | PROLV001499 | 3.41 | Protein levels | Lymphocyte | 14 | 4 | 15 | 31 | |
| 318 | Bipolar disorder | PSYCH000023 | 3.41 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 319 | CPXM1/VEGFC ratio | PRORT000737 | 3.41 | Protein ratios | Hematopoietic progenitor | 21 | 2 | 3 | 15 | |
| 320 | Vitamin D | METAB000078 | 3.40 | Metabolites | Hepatocyte | 336 | 1 | 5 | 8 | |
| 321 | SIT1 levels | PROLV001871 | 3.40 | Protein levels | Lymphocyte | 69 | 2 | 16 | 32 | |
| 322 | Height decline | BMORP000010 | 3.39 | Body morphology | Hepatocyte | 1 | 2 | 6 | 13 | |
| 323 | DLK1/RGMB ratio | PRORT000913 | 3.37 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 324 | MAVS/ZBTB16 ratio | PRORT001502 | 3.37 | Protein ratios | Muscle / cardiac | 10 | 4 | 5 | 11 | |
| 325 | Cannabis use | PSYCH000045 | 3.36 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 326 | Corrective lens use | OPHTH000032 | 3.35 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 327 | Mosaic chromosomal alteration | MISCL000014 | 3.34 | Miscellaneous | Hematopoietic progenitor | 143 | 3 | 12 | 18 | |
| 328 | ENTPD5 levels | PROLV000713 | 3.34 | Protein levels | Myeloid | 111 | 3 | 8 | 15 | |
| 329 | Hospital stay | MISCL000024 | 3.32 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 330 | PDCD1 levels | PROLV001515 | 3.31 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 331 | Medication, anti-malarial | IMMUN000083 | 3.30 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 332 | SCARA5/TNC ratio | PRORT001760 | 3.28 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 333 | CDKN1A/TACC3 ratio | PRORT000572 | 3.27 | Protein ratios | B / plasma cell | 20 | 4 | 12 | 29 | |
| 334 | FCRL5/ICAM3 ratio | PRORT001133 | 3.27 | Protein ratios | B / plasma cell | 52 | 4 | 21 | 31 | |
| 335 | AHSP/BLVRB ratio | PRORT000056 | 3.26 | Protein ratios | Stromal / connective | 33 | 2 | 13 | 32 | |
| 336 | Physical activity | BEHAV000007 | 3.26 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 337 | Reticulocyte | HEMAT000013 | 3.26 | Hematologic | Platelet | 1,657 | 4 | 2 | 9 | |
| 338 | CRYBB1 levels | PROLV000532 | 3.25 | Protein levels | Lymphocyte | 15 | 5 | 12 | 33 | |
| 339 | DRAXIN levels | PROLV000651 | 3.25 | Protein levels | B / plasma cell | 29 | 2 | 7 | 16 | |
| 340 | Vegetable preference | DTSUP000020 | 3.24 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 341 | SUGT1/TBL1X ratio | PRORT001822 | 3.24 | Protein ratios | Myeloid | 0 | 4 | 10 | 14 | |
| 342 | FSHB levels | PROLV000828 | 3.24 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 343 | MED18/SMAD1 ratio | PRORT001509 | 3.23 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 344 | Peripheral nerve disorder | NEURO000031 | 3.22 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 345 | EZR levels | PROLV000739 | 3.21 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 346 | CD27/TNFRSF13B ratio | PRORT000418 | 3.21 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 23 | |
| 347 | Occupational attainment | SOCIO000007 | 3.21 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 348 | Testosterone | ENDOC000010 | 3.21 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 349 | AXIN1/IKBKG ratio | PRORT000171 | 3.21 | Protein ratios | Muscle / cardiac | 10 | 5 | 13 | 29 | |
| 350 | RGMB/TNFRSF21 ratio | PRORT001739 | 3.21 | Protein ratios | Myeloid | 17 | 3 | 12 | 30 | |
| 351 | CXCL11/DKK1 ratio | PRORT000817 | 3.20 | Protein ratios | Myeloid | 13 | 4 | 15 | 21 | |
| 352 | GUSB levels | PROLV000946 | 3.20 | Protein levels | Hepatocyte | 109 | 2 | 9 | 12 | |
| 353 | UBAC1 levels | PROLV002132 | 3.19 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 354 | SYT1 levels | PROLV001985 | 3.18 | Protein levels | Granulosa cell | 25 | 1 | 6 | 12 | |
| 355 | FCER1A levels | PROLV000776 | 3.18 | Protein levels | Myeloid | 18 | 3 | 21 | 40 | |
| 356 | CRTAM/GZMA ratio | PRORT000769 | 3.16 | Protein ratios | Lymphocyte | 34 | 3 | 14 | 33 | |
| 357 | Medication, anti-depressant | PSYCH000019 | 3.15 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 358 | PGLYRP1 levels | PROLV001546 | 3.14 | Protein levels | Myeloid | 82 | 4 | 8 | 9 | |
| 359 | Employment status | SOCIO000005 | 3.14 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 360 | Wisdom tooth surgery | DENTA000005 | 3.12 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 361 | S100P levels | PROLV001773 | 3.12 | Protein levels | Myeloid | 20 | 4 | 10 | 14 | |
| 362 | Exercise workload | CARDI000024 | 3.12 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 363 | Pneumonopathy | RESPI000016 | 3.11 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 364 | NPTX1 levels | PROLV001426 | 3.11 | Protein levels | Platelet | 78 | 3 | 7 | 10 | |
| 365 | ADAMTS16 levels | PROLV000033 | 3.11 | Protein levels | Myeloid | 3 | 1 | 2 | 10 | |
| 366 | EDAR/PSRC1 ratio | PRORT000975 | 3.10 | Protein ratios | Platelet | 0 | 6 | 9 | 20 | |
| 367 | Nerve root disorder | NEURO000030 | 3.10 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 368 | CCL13/CCL8 ratio | PRORT000339 | 3.10 | Protein ratios | Myeloid | 0 | 2 | 7 | 27 | |
| 369 | Hyperthyroidism | ENDOC000020 | 3.10 | Endocrine | Lymphocyte | 62 | 1 | 10 | 16 | |
| 370 | CD6 levels | PROLV000349 | 3.09 | Protein levels | Lymphocyte | 89 | 2 | 19 | 32 | |
| 371 | TALDO1 levels | PROLV001991 | 3.09 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 372 | Snack and fast-food preference | DTSUP000017 | 3.09 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 373 | Lactose intolerance | METBL000003 | 3.09 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 374 | WARS levels | PROLV002183 | 3.08 | Protein levels | Lymphocyte | 52 | 3 | 12 | 28 | |
| 375 | ITGB1BP2/MED18 ratio | PRORT001384 | 3.07 | Protein ratios | Muscle / cardiac | 0 | 4 | 7 | 17 | |
| 376 | Alcohol consumption | PSYCH000041 | 3.07 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 377 | GET3 levels | PROLV000873 | 3.06 | Protein levels | B / plasma cell | 3 | 2 | 3 | 21 | |
| 378 | CHI3L1/PRSS8 ratio | PRORT000611 | 3.04 | Protein ratios | Myeloid | 7 | 5 | 11 | 23 | |
| 379 | Stressful life events | PSYCH000053 | 3.04 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 380 | Gut microbial abundance, Staphylococcus | GASTR000036 | 3.03 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 381 | Dyspnoea | RESPI000028 | 3.02 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 382 | PARP1/TCL1A ratio | PRORT001622 | 3.02 | Protein ratios | B / plasma cell | 44 | 2 | 5 | 17 | |
| 383 | FLT3LG levels | PROLV000817 | 3.02 | Protein levels | Hematopoietic progenitor | 69 | 3 | 7 | 12 | |
| 384 | Non-cancer illness burden | MISCL000029 | 3.01 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 385 | DNM3 levels | PROLV000639 | 3.01 | Protein levels | Hematopoietic progenitor | 17 | 1 | 2 | 10 | |
| 386 | CALCOCO1/INPPL1 ratio | PRORT000296 | 3.01 | Protein ratios | Granulosa cell | 0 | 2 | 11 | 25 | |
| 387 | Pain, joint | MSKEL000036 | 2.99 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 388 | Educational attainment | SOCIO000002 | 2.99 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 389 | ATG4A levels | PROLV000159 | 2.98 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 390 | NFATC3 levels | PROLV001396 | 2.97 | Protein levels | B / plasma cell | 57 | 3 | 10 | 17 | |
| 391 | Cognitive function | PSYCH000002 | 2.96 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 392 | SCARA3 levels | PROLV001779 | 2.96 | Protein levels | Epithelial | 0 | 1 | 16 | 30 | |
| 393 | Stimulant use disorder | PSYCH000048 | 2.96 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 394 | ZBTB17 levels | PROLV002210 | 2.96 | Protein levels | Muscle / cardiac | 8 | 4 | 9 | 21 | |
| 395 | Medication use | MISCL000037 | 2.95 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 396 | Body size, childhood | BMORP000004 | 2.95 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 397 | HDLBP levels | PROLV000960 | 2.95 | Protein levels | Hepatocyte | 0 | 1 | 4 | 9 | |
| 398 | Telomere length | AGING000001 | 2.94 | Aging | Hematopoietic progenitor | 228 | 2 | 10 | 22 | |
| 399 | CCL18 levels | PROLV000284 | 2.93 | Protein levels | Myeloid | 16 | 3 | 9 | 15 | |
| 400 | Carpal tunnel surgery | MSKEL000044 | 2.93 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 401 | MPIG6B/PLXNA4 ratio | PRORT001558 | 2.91 | Protein ratios | Myeloid | 21 | 2 | 7 | 14 | |
| 402 | SCARF1/TNFRSF14 ratio | PRORT001762 | 2.91 | Protein ratios | Vascular | 11 | 1 | 2 | 9 | |
| 403 | Sun exposure | BEHAV000001 | 2.91 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 404 | Respiratory symptom | RESPI000032 | 2.90 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 405 | CCL2 levels | PROLV000286 | 2.90 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 406 | EDAR/ERBIN ratio | PRORT000967 | 2.89 | Protein ratios | Myeloid | 31 | 4 | 15 | 24 | |
| 407 | CD36 levels | PROLV000337 | 2.89 | Protein levels | Myeloid | 112 | 2 | 5 | 9 | |
| 408 | PLXNA4/VASH1 ratio | PRORT001689 | 2.89 | Protein ratios | Myeloid | 4 | 6 | 15 | 24 | |
| 409 | GRAP2/MAP4K5 ratio | PRORT001241 | 2.89 | Protein ratios | Lymphocyte | 10 | 2 | 13 | 30 | |
| 410 | CCDC50 levels | PROLV000275 | 2.89 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 411 | CD40LG/TNFSF14 ratio | PRORT000454 | 2.89 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 412 | RILP levels | PROLV001734 | 2.88 | Protein levels | Lymphocyte | 22 | 2 | 15 | 42 | |
| 413 | FCER2 levels | PROLV000777 | 2.87 | Protein levels | B / plasma cell | 112 | 3 | 9 | 24 | |
| 414 | SH3GLB2 levels | PROLV001854 | 2.87 | Protein levels | Lymphocyte | 14 | 3 | 17 | 52 | |
| 415 | Osteopenia | MSKEL000009 | 2.87 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 416 | Oral health conditions, none | DENTA000009 | 2.86 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 417 | PRSS53 levels | PROLV001647 | 2.85 | Protein levels | Hepatocyte | 56 | 2 | 9 | 25 | |
| 418 | Amino acid metabolism disorder | METBL000001 | 2.82 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 419 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 2.82 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 420 | Drug hypersensitivity | IMMUN000006 | 2.82 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 421 | Menstrual disorder | REPRO000021 | 2.81 | Reproductive | Vascular | 6 | 0 | 2 | 3 | |
| 422 | Pulmonary nodule | RESPI000018 | 2.81 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 423 | SETMAR levels | PROLV001839 | 2.80 | Protein levels | Myeloid | 63 | 2 | 8 | 10 | |
| 424 | NT5C levels | PROLV001438 | 2.78 | Protein levels | Lymphocyte | 34 | 2 | 8 | 33 | |
| 425 | Organic acids | METAB000068 | 2.78 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 426 | PILRB levels | PROLV001561 | 2.77 | Protein levels | Myeloid | 43 | 2 | 6 | 10 | |
| 427 | F12 levels | PROLV000743 | 2.77 | Protein levels | Myeloid | 72 | 2 | 6 | 11 | |
| 428 | GZMA/LTA ratio | PRORT001260 | 2.77 | Protein ratios | Lymphocyte | 33 | 3 | 11 | 34 | |
| 429 | COL3A1 levels | PROLV000489 | 2.76 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 430 | GALNT10/SEMA7A ratio | PRORT001202 | 2.74 | Protein ratios | Lymphocyte | 3 | 2 | 11 | 33 | |
| 431 | METAP2/PFKFB2 ratio | PRORT001523 | 2.74 | Protein ratios | Muscle / cardiac | 1 | 3 | 9 | 18 | |
| 432 | Dairy preference | DTSUP000011 | 2.73 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 433 | PSME1 levels | PROLV001658 | 2.73 | Protein levels | Stromal / connective | 0 | 3 | 9 | 18 | |
| 434 | POSTN levels | PROLV001603 | 2.72 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 435 | DNAJC9 levels | PROLV000636 | 2.71 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 436 | CNTN5 levels | PROLV000479 | 2.70 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 437 | SNCA levels | PROLV001908 | 2.70 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 438 | Kidney failure, acute | NEPHR000012 | 2.70 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 439 | MMP8/OLR1 ratio | PRORT001543 | 2.69 | Protein ratios | Myeloid | 9 | 3 | 10 | 21 | |
| 440 | Educational attainment, none | SOCIO000001 | 2.68 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 441 | Urbanicity | SOCIO000029 | 2.67 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 442 | Latent factor, red cell | HEMAT000038 | 2.67 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 443 | Myasthenia gravis | IMMUN000035 | 2.67 | Immunologic | Lymphocyte | 54 | 1 | 13 | 36 | |
| 444 | SEPTIN3 levels | PROLV001813 | 2.67 | Protein levels | B / plasma cell | 64 | 3 | 5 | 25 | |
| 445 | GOLGA3 levels | PROLV000908 | 2.67 | Protein levels | Stromal / connective | 0 | 3 | 3 | 8 | |
| 446 | CRTAM/PDCD1 ratio | PRORT000773 | 2.67 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 447 | SCARF2/TNFRSF21 ratio | PRORT001763 | 2.66 | Protein ratios | Myeloid | 9 | 5 | 8 | 25 | |
| 448 | Phosphatidylinositols | LIPID000061 | 2.65 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 449 | ACYP1 levels | PROLV000021 | 2.65 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 450 | Dorsopathy | MSKEL000075 | 2.64 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 451 | CPB1/CTRB1 ratio | PRORT000724 | 2.63 | Protein ratios | Epithelial | 26 | 0 | 9 | 14 | |
| 452 | Iron content, Spleen | METBL000018 | 2.63 | Metabolic | Myeloid | 10 | 2 | 5 | 10 | |
| 453 | HTRA2/TRIAP1 ratio | PRORT001313 | 2.62 | Protein ratios | Myeloid | 0 | 1 | 6 | 10 | |
| 454 | Skin eruption | DERMA000027 | 2.62 | Dermatologic | Lymphocyte | 0 | 2 | 14 | 20 | |
| 455 | Coffee preference | DTSUP000002 | 2.62 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 456 | CHIT1 levels | PROLV000429 | 2.61 | Protein levels | Myeloid | 45 | 3 | 9 | 16 | |
| 457 | SPINT2/TNFSF13 ratio | PRORT001811 | 2.60 | Protein ratios | Neural / glial | 17 | 6 | 11 | 43 | |
| 458 | MOCS2 levels | PROLV001331 | 2.59 | Protein levels | Stromal / connective | 8 | 1 | 3 | 21 | |
| 459 | CPA1/CTRB1 ratio | PRORT000719 | 2.58 | Protein ratios | Pancreatic epithelium | 13 | 0 | 2 | 7 | |
| 460 | HbA1c | METBL000039 | 2.58 | Metabolic | Hematopoietic progenitor | 970 | 0 | 3 | 10 | |
| 461 | SCPEP1 levels | PROLV001792 | 2.58 | Protein levels | Muscle / cardiac | 13 | 2 | 6 | 16 | |
| 462 | CD244/EDAR ratio | PRORT000407 | 2.58 | Protein ratios | Hematopoietic progenitor | 8 | 4 | 5 | 12 | |
| 463 | CCL28 levels | PROLV000295 | 2.58 | Protein levels | Myeloid | 61 | 2 | 8 | 17 | |
| 464 | FGFBP2 levels | PROLV000799 | 2.57 | Protein levels | Myeloid | 82 | 3 | 11 | 17 | |
| 465 | SPINK2 levels | PROLV001928 | 2.57 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 466 | Supplement use, mineral or vitamin | DTSUP000026 | 2.57 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 467 | CALCOCO1/VPS53 ratio | PRORT000304 | 2.56 | Protein ratios | Epithelial | 0 | 2 | 13 | 39 | |
| 468 | GIMAP7 levels | PROLV000887 | 2.56 | Protein levels | Lymphocyte | 26 | 2 | 10 | 41 | |
| 469 | DKK1/VEGFA ratio | PRORT000904 | 2.55 | Protein ratios | Hematopoietic progenitor | 10 | 3 | 3 | 10 | |
| 470 | CHCHD6 levels | PROLV000425 | 2.55 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 471 | EDAR/TMSB10 ratio | PRORT000981 | 2.54 | Protein ratios | Myeloid | 30 | 2 | 4 | 7 | |
| 472 | Ketone bodies | METAB000056 | 2.54 | Metabolites | Hepatocyte | 118 | 1 | 6 | 7 | |
| 473 | ALDH1A1/CA2 ratio | PRORT000077 | 2.54 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 474 | CA3 levels | PROLV000244 | 2.53 | Protein levels | Muscle / cardiac | 7 | 3 | 8 | 23 | |
| 475 | ACP5 levels | PROLV000014 | 2.53 | Protein levels | Myeloid | 150 | 2 | 11 | 22 | |
| 476 | ERBB2 levels | PROLV000724 | 2.53 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 477 | RBKS levels | PROLV001709 | 2.53 | Protein levels | Hepatocyte | 23 | 1 | 7 | 17 | |
| 478 | NID2 levels | PROLV001405 | 2.53 | Protein levels | Myeloid | 59 | 2 | 7 | 15 | |
| 479 | Dietary preference | DTSUP000008 | 2.52 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 480 | Medication, chronic lung disease | RESPI000006 | 2.52 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 481 | TXN levels | PROLV002123 | 2.52 | Protein levels | Lymphocyte | 1 | 3 | 11 | 28 | |
| 482 | Brain general volume | NIMAG000015 | 2.52 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 483 | Gastric ulcer | GASTR000048 | 2.52 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 484 | CA2/CA3 ratio | PRORT000274 | 2.52 | Protein ratios | Muscle / cardiac | 0 | 3 | 11 | 23 | |
| 485 | Tyrosine metabolites | METAB000016 | 2.52 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 486 | NTF4 levels | PROLV001443 | 2.52 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 11 | |
| 487 | Commuting transport | SOCIO000004 | 2.51 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 488 | KLRK1 levels | PROLV001164 | 2.51 | Protein levels | Lymphocyte | 90 | 2 | 14 | 31 | |
| 489 | GOPC/IRAK4 ratio | PRORT001224 | 2.50 | Protein ratios | Lymphocyte | 0 | 3 | 11 | 32 | |
| 490 | PCDH9 levels | PROLV001508 | 2.50 | Protein levels | Myeloid | 32 | 2 | 9 | 15 | |
| 491 | KLK8/WFDC12 ratio | PRORT001413 | 2.50 | Protein ratios | Cutaneous epithelium | 7 | 1 | 13 | 21 | |
| 492 | PPME1 levels | PROLV001612 | 2.50 | Protein levels | Vascular | 9 | 4 | 12 | 31 | |
| 493 | Tyrosine | METAB000031 | 2.49 | Metabolites | Hepatocyte | 258 | 1 | 5 | 10 | |
| 494 | Movement disorder | NEURO000015 | 2.47 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 495 | PROK2 levels | PROLV001639 | 2.47 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 496 | Fat mass | BCOMP000005 | 2.47 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 497 | SH2D1A levels | PROLV001852 | 2.46 | Protein levels | Lymphocyte | 41 | 2 | 10 | 28 | |
| 498 | CNDP1 levels | PROLV000471 | 2.46 | Protein levels | Hepatocyte | 75 | 2 | 12 | 12 | |
| 499 | KIRREL2/PLA2G1B ratio | PRORT001406 | 2.45 | Protein ratios | Hepatocyte | 32 | 1 | 6 | 19 | |
| 500 | Eye disorder | OPHTH000008 | 2.45 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 501 | ADHD | PSYCH000033 | 2.44 | Psychiatric | Hematopoietic progenitor | 15 | 3 | 3 | 9 | |
| 502 | Sugar alcohols | METAB000037 | 2.44 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 503 | CHAC2 levels | PROLV000422 | 2.43 | Protein levels | Vascular | 4 | 3 | 10 | 21 | |
| 504 | CD40LG/SERPINE1 ratio | PRORT000453 | 2.43 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 505 | CKAP4/LTBR ratio | PRORT000622 | 2.42 | Protein ratios | Muscle / cardiac | 17 | 1 | 6 | 18 | |
| 506 | Tinnitus | AUDIO000014 | 2.42 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 507 | RBP2 levels | PROLV001711 | 2.42 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 508 | VSIG2 levels | PROLV002170 | 2.42 | Protein levels | Renal epithelium | 16 | 0 | 8 | 3 | |
| 509 | Facial ageing | DERMA000039 | 2.41 | Dermatologic | Melanocyte | 22 | 0 | 0 | 0 | |
| 510 | NPHS1 levels | PROLV001421 | 2.40 | Protein levels | Lymphocyte | 9 | 2 | 6 | 8 | |
| 511 | Latent factor, neutrophil and lymphocyte | HEMAT000035 | 2.40 | Hematologic | Myeloid | 675 | 4 | 18 | 31 | |
| 512 | Hospital admission | MISCL000022 | 2.39 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 513 | Phosphatidylethanolamines | LIPID000059 | 2.39 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 514 | PPP1R2/TBL1X ratio | PRORT001706 | 2.39 | Protein ratios | Myeloid | 14 | 3 | 13 | 18 | |
| 515 | Immune cell marker, Monocyte | HEMAT000027 | 2.38 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 516 | Lichen disorder | DERMA000013 | 2.38 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 517 | LMNB2 levels | PROLV001218 | 2.38 | Protein levels | Myeloid | 6 | 1 | 14 | 18 | |
| 518 | CRYGD levels | PROLV000534 | 2.37 | Protein levels | Hematopoietic progenitor | 17 | 1 | 5 | 20 | |
| 519 | PTPRS levels | PROLV001681 | 2.37 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 520 | ANGPT1/APP ratio | PRORT000091 | 2.36 | Protein ratios | Hematopoietic progenitor | 5 | 3 | 3 | 7 | |
| 521 | LCN2 levels | PROLV001192 | 2.36 | Protein levels | Myeloid | 43 | 1 | 7 | 12 | |
| 522 | NPTXR levels | PROLV001428 | 2.35 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 523 | Allergic rhinitis | IMMUN000004 | 2.35 | Immunologic | Lymphocyte | 125 | 2 | 14 | 18 | |
| 524 | Household size | SOCIO000011 | 2.34 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 525 | METAP2/RILP ratio | PRORT001525 | 2.34 | Protein ratios | Myeloid | 0 | 3 | 11 | 18 | |
| 526 | Digestive system symptoms | GASTR000044 | 2.34 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 527 | CTSH levels | PROLV000565 | 2.33 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 528 | METAP1D/PLXNA4 ratio | PRORT001521 | 2.32 | Protein ratios | Myeloid | 5 | 4 | 11 | 24 | |
| 529 | Dentures | DENTA000006 | 2.32 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 530 | DNMBP/WWP2 ratio | PRORT000934 | 2.32 | Protein ratios | Lymphocyte | 12 | 2 | 12 | 42 | |
| 531 | ANXA4/FADD ratio | PRORT000110 | 2.31 | Protein ratios | Hematopoietic progenitor | 0 | 1 | 4 | 9 | |
| 532 | Disability allowance, none | SOCIO000016 | 2.29 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 533 | ROBO1/SPON1 ratio | PRORT001744 | 2.29 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 534 | GALNT5 levels | PROLV000851 | 2.29 | Protein levels | Hematopoietic progenitor | 44 | 4 | 7 | 15 | |
| 535 | Urticaria | IMMUN000007 | 2.28 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 536 | CNTNAP4 levels | PROLV000481 | 2.28 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 537 | GGCT levels | PROLV000881 | 2.28 | Protein levels | Lymphocyte | 3 | 4 | 9 | 32 | |
| 538 | Pain, chronic | MSKEL000034 | 2.28 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 539 | PDZK1 levels | PROLV001531 | 2.28 | Protein levels | Hepatocyte | 27 | 3 | 12 | 25 | |
| 540 | ZNF830 levels | PROLV002212 | 2.27 | Protein levels | B / plasma cell | 4 | 4 | 11 | 30 | |
| 541 | Vehicle ownership | SOCIO000015 | 2.27 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 542 | Nerve root and plexus disorder | NEURO000029 | 2.27 | Neurologic | Myeloid | 0 | 2 | 8 | 12 | |
| 543 | Connective tissue disorder | MSKEL000060 | 2.26 | Musculoskeletal | Myeloid | 44 | 1 | 4 | 21 | |
| 544 | Dietary pattern | DTSUP000007 | 2.26 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 545 | Medication, analgesic | MISCL000034 | 2.26 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 546 | FCRL6/GZMA ratio | PRORT001137 | 2.25 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 547 | Creativity | PSYCH000003 | 2.25 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 548 | PROK1 levels | PROLV001638 | 2.25 | Protein levels | Myeloid | 74 | 2 | 15 | 17 | |
| 549 | CKAP4/LAMP3 ratio | PRORT000621 | 2.24 | Protein ratios | Epithelial | 36 | 0 | 9 | 11 | |
| 550 | HBEGF/PDGFB ratio | PRORT001269 | 2.24 | Protein ratios | Myeloid | 32 | 1 | 5 | 14 | |
| 551 | Family history, chronic lung disease | RESPI000002 | 2.23 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 552 | CEBPB/NADK ratio | PRORT000591 | 2.23 | Protein ratios | Myeloid | 1 | 1 | 6 | 15 | |
| 553 | Sinusitis | RESPI000039 | 2.23 | Respiratory | Lymphocyte | 11 | 2 | 13 | 30 | |
| 554 | Cerebellar volume | NIMAG000019 | 2.22 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 555 | MPO levels | PROLV001336 | 2.22 | Protein levels | Myeloid | 55 | 2 | 5 | 10 | |
| 556 | Meniscus surgery | MSKEL000050 | 2.22 | Musculoskeletal | Lymphocyte | 2 | 2 | 6 | 23 | |
| 557 | IL13RA1 levels | PROLV001047 | 2.22 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 558 | CDKN2D/ITGB1BP2 ratio | PRORT000578 | 2.21 | Protein ratios | Hematopoietic progenitor | 17 | 5 | 12 | 35 | |
| 559 | Flavour preference | DTSUP000022 | 2.20 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 560 | Reproductive timing | BEHAV000011 | 2.20 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 561 | CPA1/PRSS2 ratio | PRORT000722 | 2.20 | Protein ratios | Pancreatic epithelium | 17 | 0 | 5 | 9 | |
| 562 | CDKN2D/MANF ratio | PRORT000579 | 2.20 | Protein ratios | Platelet | 12 | 3 | 5 | 11 | |
| 563 | Spread preference | DTSUP000018 | 2.19 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 564 | CCL17/PDGFB ratio | PRORT000346 | 2.19 | Protein ratios | Lymphocyte | 23 | 3 | 17 | 37 | |
| 565 | CSTB levels | PROLV000553 | 2.19 | Protein levels | Muscle / cardiac | 1 | 1 | 2 | 9 | |
| 566 | PEBP1 levels | PROLV001533 | 2.19 | Protein levels | Lymphocyte | 1 | 3 | 18 | 35 | |
| 567 | LY6D/WFDC12 ratio | PRORT001470 | 2.19 | Protein ratios | Myeloid | 14 | 2 | 17 | 20 | |
| 568 | LAT/PLXNA4 ratio | PRORT001425 | 2.19 | Protein ratios | Myeloid | 18 | 3 | 12 | 26 | |
| 569 | HNRNPK levels | PROLV000982 | 2.18 | Protein levels | Lymphocyte | 0 | 4 | 10 | 31 | |
| 570 | Vertigo | AUDIO000021 | 2.18 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 571 | SLITRK2 levels | PROLV001889 | 2.17 | Protein levels | Lymphocyte | 15 | 3 | 11 | 28 | |
| 572 | CXCL5/SERPINE1 ratio | PRORT000832 | 2.17 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 573 | Medication use, pain etc, none | MISCL000032 | 2.17 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 574 | SMAD2 levels | PROLV001895 | 2.17 | Protein levels | Stromal / connective | 0 | 1 | 4 | 8 | |
| 575 | Mouth ulcers | DENTA000010 | 2.16 | Dental | Myeloid | 194 | 4 | 15 | 36 | |
| 576 | CEACAM8/MMP9 ratio | PRORT000587 | 2.16 | Protein ratios | Myeloid | 32 | 2 | 9 | 12 | |
| 577 | Social activity, none | SOCIO000018 | 2.16 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 578 | Bursitis | MSKEL000059 | 2.16 | Musculoskeletal | Hematopoietic progenitor | 0 | 1 | 3 | 7 | |
| 579 | Hydrocephalus | NEURO000002 | 2.16 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 580 | EIF4EBP1 levels | PROLV000697 | 2.16 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 581 | Sweets preference | DTSUP000019 | 2.14 | Diet and Supplement | Neural / glial | 88 | 4 | 7 | 13 | |
| 582 | Nephritic syndrome | NEPHR000009 | 2.14 | Nephrourologic | Lymphocyte | — | 2 | 9 | 21 | |
| 583 | UBXN1 levels | PROLV002134 | 2.13 | Protein levels | Lymphocyte | 5 | 4 | 15 | 38 | |
| 584 | Sleep duration | PSYCH000040 | 2.13 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 585 | NPHS2 levels | PROLV001422 | 2.13 | Protein levels | B / plasma cell | 1 | 0 | 3 | 7 | |
| 586 | CPXM1/HBEGF ratio | PRORT000733 | 2.13 | Protein ratios | Myeloid | 44 | 4 | 11 | 22 | |
| 587 | CA1/CA3 ratio | PRORT000268 | 2.13 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 588 | CRTAP levels | PROLV000531 | 2.13 | Protein levels | B / plasma cell | 49 | 3 | 11 | 21 | |
| 589 | Diglycerides | LIPID000038 | 2.12 | Lipids | Hepatocyte | 32 | 1 | 5 | 16 | |
| 590 | CTSZ/HSPG2 ratio | PRORT000804 | 2.12 | Protein ratios | Hepatocyte | 35 | 5 | 12 | 20 | |
| 591 | ERBB2/GUSB ratio | PRORT001043 | 2.12 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 592 | NELL1 levels | PROLV001390 | 2.11 | Protein levels | Renal epithelium | 16 | 0 | 8 | 22 | |
| 593 | ARG1 levels | PROLV000134 | 2.11 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 594 | IGFBP2 levels | PROLV001029 | 2.11 | Protein levels | Muscle / cardiac | 58 | 2 | 4 | 14 | |
| 595 | Autoimmune hepatitis | IMMUN000024 | 2.11 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 596 | CD244/CRTAM ratio | PRORT000406 | 2.10 | Protein ratios | Lymphocyte | 30 | 2 | 14 | 25 | |
| 597 | GDNF levels | PROLV000872 | 2.10 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 598 | EPO levels | PROLV000721 | 2.09 | Protein levels | Muscle / cardiac | 23 | 2 | 7 | 18 | |
| 599 | PLAUR/PRSS8 ratio | PRORT001679 | 2.09 | Protein ratios | Epithelial | 37 | 2 | 11 | 13 | |
| 600 | CPB1/KIRREL2 ratio | PRORT000726 | 2.09 | Protein ratios | Pancreatic epithelium | 30 | 0 | 3 | 5 | |
| 601 | ALDH1A1/RBKS ratio | PRORT000080 | 2.09 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 2 | 9 | |
| 602 | ENPP5 levels | PROLV000709 | 2.07 | Protein levels | Myeloid | 71 | 4 | 11 | 13 | |
| 603 | OSCAR levels | PROLV001474 | 2.07 | Protein levels | Hematopoietic progenitor | 181 | 4 | 9 | 11 | |
| 604 | DAB2/LYN ratio | PRORT000839 | 2.07 | Protein ratios | Myeloid | 0 | 3 | 9 | 13 | |
| 605 | ANKRD54 levels | PROLV000101 | 2.07 | Protein levels | Vascular | 2 | 2 | 4 | 18 | |
| 606 | Weight | BMORP000015 | 2.07 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 607 | BSG/LAMP3 ratio | PRORT000248 | 2.06 | Protein ratios | Myeloid | 33 | 1 | 8 | 14 | |
| 608 | DLK1/PIK3IP1 ratio | PRORT000912 | 2.06 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 609 | Digital deformity | MSKEL000053 | 2.06 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 610 | MEGF10 levels | PROLV001293 | 2.06 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 611 | AXIN1/GOPC ratio | PRORT000169 | 2.06 | Protein ratios | Platelet | 12 | 4 | 11 | 21 | |
| 612 | Low hand grip strength | MSKEL000032 | 2.06 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 613 | MYLPF levels | PROLV001361 | 2.05 | Protein levels | Muscle / cardiac | 1 | 2 | 9 | 17 | |
| 614 | MICB or MICA levels | PROLV001312 | 2.05 | Protein levels | Lymphocyte | 148 | 2 | 12 | 35 | |
| 615 | STAB2 levels | PROLV001956 | 2.05 | Protein levels | Granulosa cell | 78 | 2 | 11 | 19 | |
| 616 | PDGFB/TNFSF13 ratio | PRORT001649 | 2.05 | Protein ratios | Neural / glial | 1 | 5 | 15 | 31 | |
| 617 | CD8A levels | PROLV000361 | 2.05 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 618 | Hippocampal volume | NIMAG000024 | 2.04 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 619 | KIFBP/TACC3 ratio | PRORT001404 | 2.04 | Protein ratios | Hematopoietic progenitor | 3 | 1 | 4 | 6 | |
| 620 | BCR/ITGB1BP2 ratio | PRORT000227 | 2.04 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 621 | CHL1 levels | PROLV000430 | 2.04 | Protein levels | Hepatocyte | 10 | 3 | 6 | 15 | |
| 622 | Pancreas fat | HPBIL000028 | 2.03 | Hepatopancreatobiliary | Adipose | 11 | 0 | 5 | 6 | |
| 623 | APEX1 levels | PROLV000114 | 2.03 | Protein levels | Muscle / cardiac | 6 | 4 | 12 | 38 | |
| 624 | VEGFA levels | PROLV002157 | 2.03 | Protein levels | Muscle / cardiac | 30 | 1 | 5 | 14 | |
| 625 | CPA1/PLA2G1B ratio | PRORT000721 | 2.02 | Protein ratios | Pancreatic epithelium | 44 | 0 | 2 | 5 | |
| 626 | MSLN levels | PROLV001340 | 2.02 | Protein levels | Epithelial | 45 | 0 | 5 | 6 | |
| 627 | Dermatitis and eczema | DERMA000008 | 2.01 | Dermatologic | Lymphocyte | 129 | 1 | 12 | 18 | |
| 628 | DKK1/SERPINE1 ratio | PRORT000902 | 2.01 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 18 | |
| 629 | IL2RB levels | PROLV001070 | 2.01 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 630 | Urinary retention | NEPHR000015 | 2.01 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 631 | TCTN3 levels | PROLV002005 | 2.01 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 632 | MNX1 levels | PROLV001330 | 2.01 | Protein levels | Neural / glial | 0 | 2 | 6 | 13 | |
| 633 | Atopic dermatitis | DERMA000006 | 2.00 | Dermatologic | Lymphocyte | 115 | 2 | 13 | 11 | |
| 634 | DAB2/GRAP2 ratio | PRORT000838 | 2.00 | Protein ratios | Myeloid | 11 | 4 | 9 | 17 | |
| 635 | ACY1/SCLY ratio | PRORT000021 | 2.00 | Protein ratios | Hepatocyte | 6 | 3 | 12 | 17 | |
| 636 | Chronic bronchitis | RESPI000010 | 2.00 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 637 | CD5 levels | PROLV000344 | 2.00 | Protein levels | Lymphocyte | 116 | 3 | 9 | 29 | |
| 638 | CST6/NECTIN4 ratio | PRORT000792 | 2.00 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 639 | Sodium | METAB000050 | 2.00 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 640 | GOLM2/ITGA5 ratio | PRORT001222 | 1.99 | Protein ratios | Myeloid | 32 | 5 | 14 | 32 | |
| 641 | Psoriatic arthritis | IMMUN000040 | 1.99 | Immunologic | Lymphocyte | 88 | 2 | 15 | 20 | |
| 642 | NMT1 levels | PROLV001412 | 1.98 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 643 | LUZP2 levels | PROLV001245 | 1.98 | Protein levels | Granulosa cell | 0 | 1 | 4 | 8 | |
| 644 | Epilepsy | NEURO000034 | 1.98 | Neurologic | Myeloid | 0 | 2 | 5 | 19 | |
| 645 | CNTN3 levels | PROLV000477 | 1.98 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 646 | TNFSF13B levels | PROLV002079 | 1.98 | Protein levels | B / plasma cell | 111 | 3 | 10 | 29 | |
| 647 | CX3CL1/PODXL2 ratio | PRORT000810 | 1.97 | Protein ratios | Vascular | 14 | 3 | 10 | 15 | |
| 648 | NID1/NID2 ratio | PRORT001588 | 1.96 | Protein ratios | Lymphocyte | 3 | 3 | 8 | 25 | |
| 649 | MYOC/NOTCH3 ratio | PRORT001566 | 1.96 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 650 | ADAMTS15 levels | PROLV000032 | 1.96 | Protein levels | Hepatocyte | 42 | 1 | 7 | 9 | |
| 651 | TNF/TNFRSF1B ratio | PRORT001844 | 1.96 | Protein ratios | Myeloid | 28 | 3 | 19 | 28 | |
| 652 | ITGB1BP2/USP8 ratio | PRORT001390 | 1.96 | Protein ratios | Myeloid | 26 | 3 | 10 | 16 | |
| 653 | Functional gastrointestinal disorder | GASTR000003 | 1.95 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 654 | CXCL6/DFFA ratio | PRORT000834 | 1.95 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 18 | |
| 655 | SCN4B levels | PROLV001791 | 1.95 | Protein levels | Myeloid | 54 | 1 | 6 | 12 | |
| 656 | Coeliac disease | IMMUN000026 | 1.94 | Immunologic | Lymphocyte | 152 | 2 | 11 | 21 | |
| 657 | FETUB levels | PROLV000790 | 1.94 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 658 | Pain, back | MSKEL000033 | 1.94 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 659 | Personality disorder | PSYCH000035 | 1.93 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 660 | GSR levels | PROLV000938 | 1.93 | Protein levels | Myeloid | 12 | 3 | 11 | 26 | |
| 661 | ITGB1BP2/WASF1 ratio | PRORT001391 | 1.93 | Protein ratios | Myeloid | 0 | 3 | 9 | 24 | |
| 662 | TDP1 levels | PROLV002007 | 1.93 | Protein levels | Epithelial | 13 | 0 | 3 | 9 | |
| 663 | MICB_MICA/TEK ratio | PRORT001533 | 1.93 | Protein ratios | Myeloid | 65 | 3 | 12 | 25 | |
| 664 | Beverage preference | DTSUP000001 | 1.92 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 665 | CA11 levels | PROLV000240 | 1.91 | Protein levels | Adipose | 0 | 3 | 6 | 23 | |
| 666 | Irritable bowel syndrome | GASTR000004 | 1.91 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 667 | Otosclerosis | AUDIO000018 | 1.91 | Auditory | Granulosa cell | 16 | 5 | 10 | 16 | |
| 668 | Metabolic syndrome | METBL000015 | 1.90 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 669 | KRT19 levels | PROLV001166 | 1.90 | Protein levels | Respiratory epithelium | 46 | 0 | 11 | 7 | |
| 670 | CLEC4G/SEMA3F ratio | PRORT000663 | 1.90 | Protein ratios | Myeloid | 15 | 3 | 11 | 19 | |
| 671 | CPXM1/DKK1 ratio | PRORT000732 | 1.90 | Protein ratios | Hematopoietic progenitor | 9 | 3 | 10 | 9 | |
| 672 | Cancer, Kidney | MALIG000016 | 1.90 | Malignancy | Pancreatic epithelium | 1 | 0 | 6 | 12 | |
| 673 | Knee morphology | MSKEL000024 | 1.89 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 674 | Wheeze | RESPI000034 | 1.89 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 675 | PLB1 levels | PROLV001574 | 1.89 | Protein levels | Myeloid | 33 | 1 | 7 | 12 | |
| 676 | CPB1/PRSS2 ratio | PRORT000727 | 1.89 | Protein ratios | Granulosa cell | 22 | 0 | 1 | 6 | |
| 677 | CST1 levels | PROLV000548 | 1.89 | Protein levels | Salivary epithelium | 31 | 0 | 12 | 11 | |
| 678 | Intelligence | PSYCH000004 | 1.89 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 679 | Skin and subcutaneous tissue disorder | DERMA000004 | 1.88 | Dermatologic | Muscle / cardiac | 0 | 0 | 0 | 0 | |
| 680 | ADGRE5/SEMA7A ratio | PRORT000033 | 1.88 | Protein ratios | Myeloid | 18 | 2 | 6 | 13 | |
| 681 | GIPC2 levels | PROLV000888 | 1.88 | Protein levels | Hepatocyte | 4 | 2 | 5 | 11 | |
| 682 | EFNA4/TNFRSF9 ratio | PRORT000992 | 1.87 | Protein ratios | B / plasma cell | 16 | 3 | 18 | 25 | |
| 683 | Supplement use, dietary | DTSUP000024 | 1.87 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 684 | Tumour marker CA125 | MALIG000037 | 1.87 | Malignancy | Melanocyte | 0 | 5 | 12 | 27 | |
| 685 | Arginine metabolites | METAB000003 | 1.87 | Metabolites | B / plasma cell | 3 | 0 | 1 | 2 | |
| 686 | REN levels | PROLV001723 | 1.87 | Protein levels | Neural / glial | 2 | 0 | 3 | 8 | |
| 687 | CALCB levels | PROLV000256 | 1.87 | Protein levels | Myeloid | 1 | 0 | 3 | 2 | |
| 688 | Household composition | SOCIO000010 | 1.86 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 689 | CALCOCO1/DCTN1 ratio | PRORT000294 | 1.86 | Protein ratios | Muscle / cardiac | 0 | 3 | 9 | 21 | |
| 690 | SLIT2 levels | PROLV001887 | 1.86 | Protein levels | Neural / glial | 0 | 1 | 7 | 15 | |
| 691 | Hip circumference | BMORP000011 | 1.86 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 692 | Ventricular mass | CARDI000012 | 1.86 | Cardiac | Muscle / cardiac | 10 | 3 | 10 | 25 | |
| 693 | PPP1R14D levels | PROLV001615 | 1.86 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 694 | Noninfective gastroenteritis and colitis | GASTR000013 | 1.86 | Gastrointestinal | Myeloid | 78 | 2 | 14 | 27 | |
| 695 | CD69/PLXNA4 ratio | PRORT000494 | 1.85 | Protein ratios | Myeloid | 29 | 3 | 6 | 18 | |
| 696 | Hypothyroidism, autoimmune | IMMUN000015 | 1.85 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 697 | CD79B/FCRL1 ratio | PRORT000510 | 1.85 | Protein ratios | B / plasma cell | 29 | 3 | 11 | 23 | |
| 698 | KYNU levels | PROLV001170 | 1.85 | Protein levels | Hepatocyte | 83 | 4 | 9 | 24 | |
| 699 | FABP4/FGF21 ratio | PRORT001100 | 1.84 | Protein ratios | Hepatocyte | 48 | 1 | 7 | 13 | |
| 700 | ALDH1A1/PKLR ratio | PRORT000079 | 1.84 | Protein ratios | Myeloid | 11 | 3 | 10 | 21 | |
| 701 | GRP levels | PROLV000934 | 1.84 | Protein levels | Granulosa cell | 6 | 2 | 3 | 7 | |
| 702 | ATOX1/SPARC ratio | PRORT000152 | 1.83 | Protein ratios | Myeloid | 10 | 1 | 6 | 11 | |
| 703 | Food preparation preference | DTSUP000021 | 1.83 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 704 | ARTN levels | PROLV000148 | 1.83 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 705 | Lymphocyte | HEMAT000024 | 1.83 | Hematologic | Lymphocyte | 2,286 | 3 | 18 | 34 | |
| 706 | Latent factor, white cell | HEMAT000039 | 1.83 | Hematologic | Myeloid | 183 | 2 | 4 | 24 | |
| 707 | CYB5R2 levels | PROLV000588 | 1.83 | Protein levels | Myeloid | 6 | 1 | 4 | 8 | |
| 708 | CYTL1 levels | PROLV000589 | 1.83 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 709 | CFH levels | PROLV000413 | 1.83 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 710 | AHSG levels | PROLV000065 | 1.83 | Protein levels | Hepatocyte | 49 | 2 | 9 | 25 | |
| 711 | HDGF levels | PROLV000959 | 1.83 | Protein levels | Myeloid | 18 | 3 | 7 | 12 | |
| 712 | ITGB6 levels | PROLV001115 | 1.82 | Protein levels | Muscle / cardiac | 34 | 5 | 10 | 18 | |
| 713 | GZMA/GZMH ratio | PRORT001258 | 1.82 | Protein ratios | Lymphocyte | 23 | 2 | 12 | 23 | |
| 714 | LCN2/RETN ratio | PRORT001443 | 1.82 | Protein ratios | Myeloid | 41 | 2 | 8 | 14 | |
| 715 | LTBR/TNFRSF14 ratio | PRORT001467 | 1.81 | Protein ratios | Stromal / connective | 0 | 4 | 11 | 23 | |
| 716 | ITGB1BP2/MITD1 ratio | PRORT001385 | 1.81 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 717 | LTBP2/PDGFRA ratio | PRORT001465 | 1.81 | Protein ratios | Myeloid | 4 | 3 | 9 | 8 | |
| 718 | GOLM2 levels | PROLV000909 | 1.81 | Protein levels | Myeloid | 155 | 2 | 9 | 8 | |
| 719 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 1.81 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 720 | PRG3 levels | PROLV001629 | 1.80 | Protein levels | Lymphocyte | 126 | 2 | 8 | 27 | |
| 721 | F8 levels | PROLV000749 | 1.79 | Protein levels | Neural / glial | 2 | 2 | 6 | 11 | |
| 722 | CCL19 levels | PROLV000285 | 1.79 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 723 | Medication, Crohn disease | IMMUN000081 | 1.79 | Immunologic | Lymphocyte | 132 | 2 | 17 | 10 | |
| 724 | Immune cell marker, CD8 T cell | HEMAT000023 | 1.79 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 725 | DKKL1 levels | PROLV000623 | 1.79 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 726 | MED18/TBL1X ratio | PRORT001511 | 1.78 | Protein ratios | Myeloid | 35 | 3 | 11 | 22 | |
| 727 | DKK3 levels | PROLV000621 | 1.78 | Protein levels | Myeloid | 56 | 3 | 10 | 17 | |
| 728 | Medication, thyroid | ENDOC000002 | 1.78 | Endocrine | Lymphocyte | 202 | 1 | 13 | 19 | |
| 729 | Other ear disorder | AUDIO000004 | 1.78 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 730 | GLRX2 levels | PROLV000897 | 1.78 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 731 | FABP1 levels | PROLV000751 | 1.78 | Protein levels | Neural / glial | 0 | 2 | 9 | 16 | |
| 732 | Weight change | BMORP000016 | 1.77 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 733 | CES2 levels | PROLV000406 | 1.77 | Protein levels | Myeloid | 38 | 2 | 10 | 11 | |
| 734 | KLF4 levels | PROLV001149 | 1.77 | Protein levels | Lymphocyte | 0 | 2 | 7 | 21 | |
| 735 | TYRO3 levels | PROLV002129 | 1.77 | Protein levels | Lymphocyte | 36 | 1 | 9 | 30 | |
| 736 | Depression or anxiety | PSYCH000025 | 1.77 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 737 | Medication, dysmenorrhea | REPRO000018 | 1.76 | Reproductive | Myeloid | 11 | 0 | 4 | 8 | |
| 738 | NAGPA levels | PROLV001373 | 1.75 | Protein levels | Hepatocyte | 66 | 1 | 4 | 14 | |
| 739 | Spleen volume | HEMAT000042 | 1.75 | Hematologic | B / plasma cell | 17 | 4 | 8 | 13 | |
| 740 | PAG1 levels | PROLV001487 | 1.75 | Protein levels | Lymphocyte | 60 | 4 | 18 | 30 | |
| 741 | SLAMF1 levels | PROLV001875 | 1.75 | Protein levels | B / plasma cell | 22 | 2 | 12 | 27 | |
| 742 | Inflammation and poor diet | MISCL000001 | 1.75 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 743 | White matter volume | NIMAG000028 | 1.75 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 744 | MOG/SEZ6L ratio | PRORT001553 | 1.74 | Protein ratios | Myeloid | 7 | 2 | 9 | 13 | |
| 745 | LRP11/ROR1 ratio | PRORT001461 | 1.74 | Protein ratios | Vascular | 0 | 0 | 4 | 10 | |
| 746 | ATXN10/SLC27A4 ratio | PRORT000163 | 1.73 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 747 | SRPX levels | PROLV001945 | 1.73 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 748 | Epigenetic age acceleration | AGING000002 | 1.73 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 749 | ITGB1BP2/STAT5B ratio | PRORT001388 | 1.73 | Protein ratios | Muscle / cardiac | 13 | 2 | 7 | 24 | |
| 750 | BLMH/PEAR1 ratio | PRORT000236 | 1.73 | Protein ratios | Hepatocyte | 17 | 3 | 13 | 15 | |
| 751 | Sleep disorder | PSYCH000039 | 1.73 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 752 | Medication, analgesic or antidepressant | MISCL000033 | 1.73 | Miscellaneous | Lymphocyte | 0 | 3 | 16 | 43 | |
| 753 | PILRA levels | PROLV001560 | 1.73 | Protein levels | Myeloid | 54 | 1 | 9 | 10 | |
| 754 | Falling risk | MISCL000040 | 1.72 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 755 | CSF3R levels | PROLV000541 | 1.72 | Protein levels | Myeloid | 76 | 1 | 4 | 10 | |
| 756 | Cough | RESPI000027 | 1.72 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 757 | ITGB1BP2 levels | PROLV001112 | 1.72 | Protein levels | Myeloid | 18 | 1 | 2 | 8 | |
| 758 | LILRB1 levels | PROLV001213 | 1.72 | Protein levels | B / plasma cell | 214 | 5 | 14 | 33 | |
| 759 | Mood symptoms | PSYCH000029 | 1.72 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 760 | IGBP1 levels | PROLV001023 | 1.72 | Protein levels | Lymphocyte | 1 | 3 | 12 | 33 | |
| 761 | Hair pigmentation | DERMA000025 | 1.71 | Dermatologic | Melanocyte | 189 | 2 | 7 | 22 | |
| 762 | Bacterial infections | IMMUN000051 | 1.71 | Immunologic | Myeloid | 17 | 5 | 13 | 30 | |
| 763 | VSIG10 levels | PROLV002169 | 1.70 | Protein levels | Muscle / cardiac | 3 | 1 | 4 | 7 | |
| 764 | Waist circumference | BMORP000013 | 1.70 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 765 | PALM levels | PROLV001489 | 1.70 | Protein levels | Granulosa cell | 28 | 1 | 7 | 8 | |
| 766 | C1QTNF1 levels | PROLV000224 | 1.70 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 767 | S100A14 levels | PROLV001769 | 1.70 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 768 | PRUNE2 levels | PROLV001652 | 1.70 | Protein levels | Hepatocyte | 23 | 1 | 3 | 15 | |
| 769 | CCS levels | PROLV000307 | 1.70 | Protein levels | Lymphocyte | 50 | 2 | 13 | 44 | |
| 770 | Medication, insulin therapy | METBL000027 | 1.69 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 771 | Lysophosphatidylethanolamines | LIPID000055 | 1.69 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 772 | FABP6 levels | PROLV000756 | 1.69 | Protein levels | Vascular | 4 | 2 | 7 | 11 | |
| 773 | GPLD1 levels | PROLV000926 | 1.68 | Protein levels | Lymphocyte | 0 | 1 | 4 | 8 | |
| 774 | APP/HBEGF ratio | PRORT000126 | 1.68 | Protein ratios | Myeloid | 46 | 5 | 17 | 26 | |
| 775 | CD2AP levels | PROLV000328 | 1.68 | Protein levels | Vascular | 8 | 3 | 8 | 33 | |
| 776 | Bone and cartilage disorder | MSKEL000006 | 1.68 | Musculoskeletal | Neural / glial | 1 | 0 | 0 | 4 | |
| 777 | KLRB1 levels | PROLV001161 | 1.68 | Protein levels | Lymphocyte | 88 | 2 | 17 | 26 | |
| 778 | Arthropathy | MSKEL000013 | 1.68 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 779 | CD22 levels | PROLV000320 | 1.68 | Protein levels | B / plasma cell | 103 | 2 | 9 | 20 | |
| 780 | Physical decline | AGING000005 | 1.68 | Aging | Muscle / cardiac | 0 | 4 | 15 | 14 | |
| 781 | RETN/RNASET2 ratio | PRORT001735 | 1.68 | Protein ratios | Myeloid | 43 | 2 | 10 | 10 | |
| 782 | JAM2/TNFRSF21 ratio | PRORT001401 | 1.68 | Protein ratios | Vascular | 4 | 1 | 6 | 7 | |
| 783 | HBEGF/SDC4 ratio | PRORT001271 | 1.67 | Protein ratios | Myeloid | 56 | 2 | 9 | 18 | |
| 784 | Cancer, Melanoma | MALIG000020 | 1.67 | Malignancy | Lymphocyte | 121 | 2 | 5 | 25 | |
| 785 | SRP14 levels | PROLV001943 | 1.67 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 786 | CD58/IL10RB ratio | PRORT000474 | 1.66 | Protein ratios | Myeloid | 4 | 2 | 5 | 7 | |
| 787 | CXCL1 levels | PROLV000575 | 1.66 | Protein levels | Granulosa cell | 44 | 2 | 6 | 9 | |
| 788 | CD1C levels | PROLV000315 | 1.66 | Protein levels | Myeloid | 118 | 2 | 7 | 9 | |
| 789 | COL6A3/COLEC12 ratio | PRORT000695 | 1.66 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 790 | Short-chain fatty acids | METAB000053 | 1.66 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 791 | Citrulline | METAB000020 | 1.66 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 792 | Eosinophil | HEMAT000030 | 1.66 | Hematologic | Lymphocyte | 1,935 | 2 | 16 | 25 | |
| 793 | CWC15 levels | PROLV000572 | 1.66 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 794 | PLXNB2/SEMA7A ratio | PRORT001690 | 1.65 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 21 | |
| 795 | AZU1/RNASE3 ratio | PRORT000186 | 1.65 | Protein ratios | Myeloid | 1 | 2 | 4 | 11 | |
| 796 | NCR1 levels | PROLV001382 | 1.64 | Protein levels | Lymphocyte | 117 | 2 | 14 | 32 | |
| 797 | PCOLCE levels | PROLV001510 | 1.64 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 798 | Cancer, Endometrium | MALIG000014 | 1.64 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 799 | LTA4H levels | PROLV001240 | 1.64 | Protein levels | Muscle / cardiac | 0 | 3 | 16 | 38 | |
| 800 | RNF43 levels | PROLV001747 | 1.64 | Protein levels | Melanocyte | 0 | 1 | 1 | 3 | |
| 801 | ADA levels | PROLV000023 | 1.63 | Protein levels | Myeloid | 17 | 5 | 18 | 32 | |
| 802 | MANSC1 levels | PROLV001263 | 1.63 | Protein levels | Hepatocyte | 146 | 1 | 7 | 12 | |
| 803 | Upper respiratory tract disease | RESPI000042 | 1.63 | Respiratory | Lymphocyte | 13 | 2 | 19 | 32 | |
| 804 | IFNLR1 levels | PROLV001022 | 1.63 | Protein levels | Hepatocyte | 49 | 2 | 7 | 19 | |
| 805 | RNASE3 levels | PROLV001738 | 1.62 | Protein levels | Myeloid | 39 | 4 | 15 | 28 | |
| 806 | HLAE/IL15 ratio | PRORT001287 | 1.62 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 807 | CRISP3 levels | PROLV000525 | 1.62 | Protein levels | Hematopoietic progenitor | 88 | 3 | 9 | 12 | |
| 808 | MMP8/PGLYRP1 ratio | PRORT001544 | 1.62 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 809 | ATP5IF1/FIS1 ratio | PRORT000156 | 1.62 | Protein ratios | Myeloid | 28 | 3 | 11 | 12 | |
| 810 | CD300LF levels | PROLV000332 | 1.61 | Protein levels | Myeloid | 40 | 2 | 8 | 17 | |
| 811 | ATXN10/CASP10 ratio | PRORT000161 | 1.61 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 812 | ICAM5 levels | PROLV001008 | 1.61 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 813 | ELOA/MAD1L1 ratio | PRORT001015 | 1.60 | Protein ratios | Myeloid | 4 | 3 | 9 | 15 | |
| 814 | LAMP3 levels | PROLV001182 | 1.60 | Protein levels | Myeloid | 82 | 2 | 10 | 20 | |
| 815 | GP6/SCARF1 ratio | PRORT001234 | 1.60 | Protein ratios | Myeloid | 6 | 2 | 11 | 15 | |
| 816 | ANGPT2 levels | PROLV000094 | 1.60 | Protein levels | Hepatocyte | 72 | 3 | 10 | 21 | |
| 817 | CCL13 levels | PROLV000279 | 1.59 | Protein levels | Myeloid | 139 | 1 | 8 | 13 | |
| 818 | Gut microbial abundance, Rubneribacter | GASTR000035 | 1.59 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 819 | EDAR/LAT2 ratio | PRORT000973 | 1.59 | Protein ratios | Myeloid | 1 | 5 | 15 | 23 | |
| 820 | Thyrotoxicosis | ENDOC000024 | 1.58 | Endocrine | Lymphocyte | 91 | 1 | 11 | 19 | |
| 821 | NSFL1C levels | PROLV001437 | 1.58 | Protein levels | Vascular | 9 | 1 | 8 | 21 | |
| 822 | CD27/TGFBR2 ratio | PRORT000417 | 1.58 | Protein ratios | B / plasma cell | 29 | 3 | 10 | 19 | |
| 823 | DYNLL1 levels | PROLV000666 | 1.58 | Protein levels | B / plasma cell | 0 | 1 | 4 | 4 | |
| 824 | CD99/MMP3 ratio | PRORT000535 | 1.58 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 825 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 1.57 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 826 | Grey matter volume | NIMAG000023 | 1.57 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 827 | NID1/SORT1 ratio | PRORT001589 | 1.57 | Protein ratios | Myeloid | 11 | 1 | 5 | 8 | |
| 828 | TNFAIP8 levels | PROLV002055 | 1.57 | Protein levels | Muscle / cardiac | 0 | 2 | 5 | 11 | |
| 829 | Hypothyroidism | ENDOC000021 | 1.57 | Endocrine | Lymphocyte | 371 | 1 | 12 | 20 | |
| 830 | FCRL6 levels | PROLV000787 | 1.56 | Protein levels | Lymphocyte | 109 | 2 | 11 | 30 | |
| 831 | Vestibular disorder | AUDIO000022 | 1.56 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 832 | IGSF21 levels | PROLV001037 | 1.56 | Protein levels | Myeloid | 49 | 3 | 9 | 13 | |
| 833 | ITGA5/VCAM1 ratio | PRORT001373 | 1.56 | Protein ratios | Myeloid | 15 | 4 | 10 | 19 | |
| 834 | Gut microbial abundance, Alistipes | GASTR000018 | 1.56 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 835 | ITGA6/THPO ratio | PRORT001374 | 1.56 | Protein ratios | Hepatocyte | 54 | 2 | 12 | 27 | |
| 836 | FADD/PPP1R2 ratio | PRORT001109 | 1.56 | Protein ratios | Myeloid | 14 | 1 | 7 | 13 | |
| 837 | Insomnia | PSYCH000038 | 1.56 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 838 | RILPL2 levels | PROLV001735 | 1.56 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 839 | Alpha-1-antitrypsin deficiency | RESPI000005 | 1.55 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 840 | RNASE6 levels | PROLV001740 | 1.55 | Protein levels | Myeloid | 66 | 2 | 5 | 13 | |
| 841 | CDKN2D/TACC3 ratio | PRORT000580 | 1.55 | Protein ratios | Hematopoietic progenitor | 1 | 4 | 11 | 29 | |
| 842 | DBNL/DNAJA2 ratio | PRORT000864 | 1.55 | Protein ratios | Muscle / cardiac | 22 | 6 | 15 | 21 | |
| 843 | Psoriasis | IMMUN000039 | 1.54 | Immunologic | Lymphocyte | 213 | 2 | 14 | 19 | |
| 844 | Pregnancy complication, ectopic | REPRO000028 | 1.54 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 845 | Immune cell marker, B cell | HEMAT000021 | 1.54 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 846 | ASPN levels | PROLV000153 | 1.54 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 847 | HEXIM1/TBL1X ratio | PRORT001280 | 1.53 | Protein ratios | Myeloid | 4 | 3 | 12 | 30 | |
| 848 | CRTAM/FCRL6 ratio | PRORT000768 | 1.53 | Protein ratios | Lymphocyte | 37 | 2 | 12 | 22 | |
| 849 | SNX15 levels | PROLV001911 | 1.53 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 850 | Anal and rectal disorder | GASTR000001 | 1.53 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 851 | Cancer, Skin | MALIG000028 | 1.53 | Malignancy | Lymphocyte | 302 | 3 | 14 | 19 | |
| 852 | Cholesteryl esters | LIPID000019 | 1.52 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 853 | ANXA3/EDAR ratio | PRORT000105 | 1.52 | Protein ratios | Myeloid | 22 | 1 | 3 | 6 | |
| 854 | CD38/RELT ratio | PRORT000440 | 1.52 | Protein ratios | Muscle / cardiac | 2 | 2 | 9 | 17 | |
| 855 | SNAP23/TXLNA ratio | PRORT001795 | 1.52 | Protein ratios | Hepatocyte | 0 | 2 | 12 | 24 | |
| 856 | BLMH/SERPINE1 ratio | PRORT000237 | 1.52 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 857 | Severe mental illness | PSYCH000017 | 1.52 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 858 | Paradoxical eczema | IMMUN000036 | 1.52 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 859 | Autoimmune disease | IMMUN000023 | 1.51 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 860 | Medication, GERD | GASTR000014 | 1.51 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 861 | CLEC7A levels | PROLV000457 | 1.51 | Protein levels | Myeloid | 64 | 1 | 5 | 15 | |
| 862 | CNP levels | PROLV000472 | 1.51 | Protein levels | Stromal / connective | 1 | 3 | 9 | 29 | |
| 863 | SSC4D levels | PROLV001947 | 1.51 | Protein levels | Hepatocyte | 51 | 3 | 8 | 15 | |
| 864 | CDH5/PCDH17 ratio | PRORT000559 | 1.51 | Protein ratios | Vascular | 23 | 2 | 8 | 6 | |
| 865 | CSNK1D levels | PROLV000542 | 1.51 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 866 | CCN4 levels | PROLV000304 | 1.51 | Protein levels | Platelet | 32 | 1 | 3 | 6 | |
| 867 | KIR3DL1 levels | PROLV001143 | 1.50 | Protein levels | Lymphocyte | 97 | 3 | 13 | 37 | |
| 868 | Medication, bone metabolism | MSKEL000025 | 1.50 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 869 | SERPINE1/SPARC ratio | PRORT001778 | 1.50 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 13 | |
| 870 | CA5A/GRPEL1 ratio | PRORT000286 | 1.50 | Protein ratios | Hepatocyte | 44 | 3 | 12 | 25 | |
| 871 | TREML1 levels | PROLV002103 | 1.50 | Protein levels | Lymphocyte | 27 | 2 | 7 | 19 | |
| 872 | ATP5IF1/METAP1D ratio | PRORT000160 | 1.50 | Protein ratios | Myeloid | 6 | 3 | 9 | 28 | |
| 873 | Cancer, Small intestine | MALIG000029 | 1.49 | Malignancy | Neural / glial | 1 | 1 | 5 | 6 | |
| 874 | VEGFB levels | PROLV002158 | 1.49 | Protein levels | Lymphocyte | 54 | 3 | 14 | 35 | |
| 875 | SERPINB13 levels | PROLV001824 | 1.49 | Protein levels | Hepatocyte | 0 | 1 | 11 | 15 | |
| 876 | BLNK levels | PROLV000200 | 1.49 | Protein levels | B / plasma cell | 0 | 3 | 15 | 27 | |
| 877 | Study participation | BEHAV000004 | 1.49 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 878 | Gut microbial abundance, Bifidobacterium | GASTR000019 | 1.48 | Gastrointestinal | B / plasma cell | 0 | 3 | 6 | 20 | |
| 879 | CPA4 levels | PROLV000503 | 1.48 | Protein levels | Myeloid | 3 | 3 | 8 | 8 | |
| 880 | CA1/CA2 ratio | PRORT000267 | 1.48 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 881 | Monocyte | HEMAT000032 | 1.48 | Hematologic | Myeloid | 3,034 | 2 | 6 | 9 | |
| 882 | IL10RB levels | PROLV001043 | 1.47 | Protein levels | Granulosa cell | 21 | 1 | 8 | 7 | |
| 883 | Surgical history | MISCL000031 | 1.47 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 884 | Enthesopathy | MSKEL000061 | 1.46 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 885 | CA4/TNFSF12 ratio | PRORT000285 | 1.46 | Protein ratios | Myeloid | 16 | 3 | 6 | 18 | |
| 886 | GSTT2B levels | PROLV000943 | 1.46 | Protein levels | Muscle / cardiac | 20 | 2 | 5 | 11 | |
| 887 | Benign neoplasm, Adipose | MALIG000001 | 1.46 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 888 | FURIN/PLA2G15 ratio | PRORT001185 | 1.46 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 889 | Brain structural connectivity | NIMAG000007 | 1.45 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 890 | Acquired foot deformities | MSKEL000052 | 1.45 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 891 | Pyloric stenosis | GASTR000052 | 1.45 | Gastrointestinal | B / plasma cell | 0 | 0 | 6 | 6 | |
| 892 | PON1 levels | PROLV001600 | 1.45 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 893 | LYVE1 levels | PROLV001254 | 1.44 | Protein levels | Myeloid | 54 | 2 | 8 | 10 | |
| 894 | Negative affect | PSYCH000030 | 1.44 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 895 | Circadian timing | BEHAV000014 | 1.44 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 896 | OCLN levels | PROLV001461 | 1.44 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 897 | Phosphatidylcholines | LIPID000058 | 1.43 | Lipids | Hepatocyte | 408 | 1 | 3 | 17 | |
| 898 | FHIT levels | PROLV000805 | 1.43 | Protein levels | Lymphocyte | 15 | 3 | 8 | 40 | |
| 899 | CD79B levels | PROLV000356 | 1.43 | Protein levels | B / plasma cell | 22 | 1 | 6 | 5 | |
| 900 | Viral haemorrhagic fever | IMMUN000075 | 1.43 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 901 | Depression | PSYCH000024 | 1.43 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 902 | Leg fat percentage | BCOMP000015 | 1.42 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 903 | CRADD/EREG ratio | PRORT000744 | 1.42 | Protein ratios | Myeloid | 1 | 3 | 9 | 17 | |
| 904 | MZB1 levels | PROLV001366 | 1.42 | Protein levels | Lymphocyte | 62 | 2 | 12 | 17 | |
| 905 | YWHAQ levels | PROLV002208 | 1.42 | Protein levels | Vascular | 9 | 4 | 10 | 21 | |
| 906 | RET levels | PROLV001724 | 1.42 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 907 | GTPBP2 levels | PROLV000944 | 1.41 | Protein levels | Lymphocyte | 6 | 4 | 9 | 17 | |
| 908 | FCAR levels | PROLV000775 | 1.41 | Protein levels | Myeloid | 87 | 2 | 7 | 13 | |
| 909 | Otitis externa | AUDIO000003 | 1.41 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 910 | RNF41/WWP2 ratio | PRORT001743 | 1.41 | Protein ratios | Epithelial | 0 | 0 | 7 | 6 | |
| 911 | LYN/SIRT2 ratio | PRORT001472 | 1.40 | Protein ratios | Lymphocyte | 5 | 1 | 5 | 11 | |
| 912 | NCF2 levels | PROLV001380 | 1.40 | Protein levels | Muscle / cardiac | 2 | 2 | 7 | 14 | |
| 913 | BMPER levels | PROLV000206 | 1.40 | Protein levels | Myeloid | 1 | 1 | 8 | 12 | |
| 914 | Neoplasm, uncertain behaviour | MALIG000035 | 1.40 | Malignancy | Lymphocyte | 1 | 2 | 9 | 26 | |
| 915 | DOK2/PDLIM7 ratio | PRORT000940 | 1.39 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 916 | TRIM40 levels | PROLV002109 | 1.39 | Protein levels | Muscle / cardiac | 52 | 4 | 10 | 9 | |
| 917 | Amino sugar metabolites | METAB000034 | 1.39 | Metabolites | Lymphocyte | 0 | 1 | 5 | 20 | |
| 918 | LATS1 levels | PROLV001186 | 1.39 | Protein levels | Myeloid | 4 | 3 | 6 | 16 | |
| 919 | ARNT levels | PROLV000144 | 1.39 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 920 | CD48/FCRL6 ratio | PRORT000464 | 1.39 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 921 | EDIL3 levels | PROLV000675 | 1.38 | Protein levels | Lymphocyte | 4 | 2 | 10 | 30 | |
| 922 | NBN levels | PROLV001376 | 1.38 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 923 | MCAM/NCAM1 ratio | PRORT001505 | 1.38 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 924 | Diabetes, type 1 | IMMUN000012 | 1.38 | Immunologic | Lymphocyte | 291 | 2 | 14 | 6 | |
| 925 | ZNRD2 levels | PROLV002213 | 1.38 | Protein levels | B / plasma cell | 62 | 2 | 14 | 25 | |
| 926 | CD6/EZR ratio | PRORT000484 | 1.38 | Protein ratios | Myeloid | 15 | 5 | 18 | 43 | |
| 927 | CXCL17/LAMP3 ratio | PRORT000823 | 1.37 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 928 | TFRC levels | PROLV002017 | 1.37 | Protein levels | Myeloid | 70 | 3 | 7 | 24 | |
| 929 | CD27/DLL1 ratio | PRORT000412 | 1.37 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 930 | NSFL1C/RILP ratio | PRORT001600 | 1.37 | Protein ratios | Neural / glial | 57 | 6 | 11 | 31 | |
| 931 | NHLRC3 levels | PROLV001403 | 1.37 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 932 | GDF15 levels | PROLV000869 | 1.37 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 933 | Supplement use, mineral or vitamin, none | DTSUP000027 | 1.37 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 934 | CD5/TNFRSF9 ratio | PRORT000468 | 1.37 | Protein ratios | Lymphocyte | 46 | 2 | 16 | 41 | |
| 935 | NUBP1 levels | PROLV001450 | 1.36 | Protein levels | B / plasma cell | 26 | 1 | 8 | 16 | |
| 936 | IL2RA levels | PROLV001069 | 1.36 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 937 | CA2/PSMG3 ratio | PRORT000277 | 1.36 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 938 | Cholesterol, HDL x psychiatric interaction | LIPID000002 | 1.36 | Lipids | Myeloid | 136 | 3 | 8 | 16 | |
| 939 | QPCT levels | PROLV001693 | 1.36 | Protein levels | Lymphocyte | 72 | 3 | 9 | 24 | |
| 940 | FGF2 levels | PROLV000794 | 1.36 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 941 | Subcortical volume | NIMAG000026 | 1.35 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 942 | Glycine metabolites | METAB000007 | 1.35 | Metabolites | Hepatocyte | 13 | 1 | 2 | 12 | |
| 943 | IgA nephropathy | NEPHR000007 | 1.35 | Nephrourologic | Hepatocyte | — | 0 | 3 | 8 | |
| 944 | Trigger finger | MSKEL000072 | 1.35 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 945 | KLRF1 levels | PROLV001163 | 1.34 | Protein levels | Lymphocyte | 134 | 3 | 14 | 15 | |
| 946 | Family history, hypertension | VASCU000022 | 1.34 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 947 | EREG/TIMP3 ratio | PRORT001059 | 1.34 | Protein ratios | Myeloid | 5 | 2 | 13 | 18 | |
| 948 | IPCEF1/TBCC ratio | PRORT001365 | 1.34 | Protein ratios | B / plasma cell | 1 | 1 | 11 | 17 | |
| 949 | Ankle spacing width | MSKEL000056 | 1.34 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 950 | CLEC4G/KEL ratio | PRORT000659 | 1.33 | Protein ratios | Myeloid | 43 | 2 | 12 | 33 | |
| 951 | KIR2DL2 levels | PROLV001141 | 1.33 | Protein levels | Lymphocyte | 166 | 2 | 14 | 29 | |
| 952 | Cancer, Lip | MALIG000017 | 1.33 | Malignancy | Lymphocyte | 0 | 3 | 11 | 39 | |
| 953 | CA3/HMBS ratio | PRORT000280 | 1.33 | Protein ratios | B / plasma cell | 12 | 4 | 15 | 37 | |
| 954 | CLIC5 levels | PROLV000458 | 1.33 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 955 | Frailty, disability | MISCL000038 | 1.33 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 956 | CXCL5/SPARC ratio | PRORT000833 | 1.32 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 957 | CLEC4G/LGALS4 ratio | PRORT000660 | 1.32 | Protein ratios | Myeloid | 26 | 2 | 10 | 19 | |
| 958 | SPON1 levels | PROLV001936 | 1.32 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 959 | FUT8/TNFSF12 ratio | PRORT001191 | 1.32 | Protein ratios | Platelet | 11 | 4 | 15 | 30 | |
| 960 | CREG1 levels | PROLV000517 | 1.31 | Protein levels | Hepatocyte | 128 | 2 | 13 | 21 | |
| 961 | Narcolepsy | NEURO000036 | 1.31 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 962 | CCN2/VEGFC ratio | PRORT000371 | 1.31 | Protein ratios | Hematopoietic progenitor | 24 | 4 | 9 | 19 | |
| 963 | Acute appendicitis | GASTR000009 | 1.31 | Gastrointestinal | Myeloid | 28 | 1 | 2 | 7 | |
| 964 | ASGR1 levels | PROLV000151 | 1.30 | Protein levels | Hepatocyte | 61 | 5 | 15 | 29 | |
| 965 | PRSS8 levels | PROLV001648 | 1.30 | Protein levels | Epithelial | 26 | 1 | 5 | 8 | |
| 966 | S100A12 levels | PROLV001767 | 1.30 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 967 | CD58/TYRO3 ratio | PRORT000480 | 1.30 | Protein ratios | Myeloid | 0 | 0 | 4 | 7 | |
| 968 | PPM1F levels | PROLV001611 | 1.29 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 969 | Skin sebum | DERMA000036 | 1.29 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 970 | Kidney failure | NEPHR000013 | 1.29 | Nephrourologic | Hepatocyte | 61 | 1 | 4 | 5 | |
| 971 | Anxiety | PSYCH000022 | 1.29 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 972 | PLXNA4/SRPK2 ratio | PRORT001686 | 1.29 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 973 | SCARF1 levels | PROLV001782 | 1.29 | Protein levels | Lymphocyte | 25 | 3 | 8 | 13 | |
| 974 | ARHGAP25/RNF41 ratio | PRORT000139 | 1.29 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 975 | COL6A3/HSPG2 ratio | PRORT000697 | 1.29 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 976 | PALM3 levels | PROLV001491 | 1.28 | Protein levels | Myeloid | 37 | 2 | 7 | 12 | |
| 977 | IL5RA/TNFRSF13B ratio | PRORT001352 | 1.28 | Protein ratios | B / plasma cell | 63 | 3 | 16 | 21 | |
| 978 | Gut microbial abundance, Chromatiales | GASTR000024 | 1.28 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 979 | SPINK6 levels | PROLV001931 | 1.28 | Protein levels | Cutaneous epithelium | 0 | 1 | 13 | 10 | |
| 980 | CRACR2A/LBR ratio | PRORT000741 | 1.28 | Protein ratios | Myeloid | 0 | 3 | 17 | 17 | |
| 981 | MAP2K6/MGMT ratio | PRORT001485 | 1.28 | Protein ratios | Epithelial | 0 | 0 | 11 | 12 | |
| 982 | EFEMP1/FSTL3 ratio | PRORT000986 | 1.28 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 983 | BCR/DECR1 ratio | PRORT000223 | 1.28 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 31 | |
| 984 | IGSF9 levels | PROLV001040 | 1.28 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 985 | CCBL2 levels | PROLV000274 | 1.28 | Protein levels | Neural / glial | 0 | 0 | 7 | 13 | |
| 986 | RRM2B/SMAD1 ratio | PRORT001749 | 1.27 | Protein ratios | Hepatocyte | 1 | 1 | 5 | 18 | |
| 987 | CIAPIN1/SNX9 ratio | PRORT000617 | 1.27 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 988 | Dietary change, none | DTSUP000005 | 1.27 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 989 | Body fat percentage, sex interaction | BCOMP000002 | 1.26 | Body composition | Muscle / cardiac | 0 | 2 | 6 | 13 | |
| 990 | Thyroid disorder | ENDOC000023 | 1.26 | Endocrine | Lymphocyte | 189 | 1 | 10 | 25 | |
| 991 | FURIN levels | PROLV000835 | 1.26 | Protein levels | Myeloid | 29 | 3 | 8 | 13 | |
| 992 | CEP43/MPHOSPH8 ratio | PRORT000599 | 1.26 | Protein ratios | Myeloid | 3 | 3 | 8 | 23 | |
| 993 | Bronchitis | RESPI000001 | 1.26 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 994 | CLC levels | PROLV000443 | 1.26 | Protein levels | Lymphocyte | 65 | 3 | 19 | 17 | |
| 995 | Asthma | IMMUN000005 | 1.26 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 996 | Nasal polyp | RESPI000037 | 1.26 | Respiratory | Lymphocyte | 11 | 2 | 11 | 20 | |
| 997 | IL1RL2 levels | PROLV001064 | 1.26 | Protein levels | Hepatocyte | 200 | 2 | 12 | 23 | |
| 998 | PPT1 levels | PROLV001621 | 1.26 | Protein levels | Melanocyte | 2 | 3 | 7 | 26 | |
| 999 | SEZ6L levels | PROLV001841 | 1.26 | Protein levels | Myeloid | 76 | 2 | 8 | 7 | |
| 1000 | TRAF2/WWP2 ratio | PRORT001857 | 1.26 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 51 |